Discover top B2B leads for Pharmaceuticals industry
Identify and research relevant prospects for B2B lead generation on Pharmaceuticals sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for businesses based on their specifics like location, name or category.
AbbVie
AbbVie is a pharmaceutical company that discovers,Show more... develops, and markets medicines.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active
338 Emails
0 Phones
Main email format: sarah.smith@abbvie.com (47.2%)
-
Melanie Cohen
m***********n@abbvie.com
-
Nancy Vangeys
n***********s@abbvie.com
-
Andrew Dillard
a************d@abbvie.com
-
Jennifer Langan
j*************n@abbvie.com
-
Jay Stamatis
j**********s@abbvie.com
-
Miki Mancine
m**********e@abbvie.com
-
Catherine Desjardins
Regional Manager, Market Access and Government Affairs in Oncology
c******************s@abbvie.com
-
Felix J Gonzalezreyes
f*****************s@abbvie.com
-
Ateet Shah
a********h@abbvie.com
-
Robert Michael
President and Chief Operating Officer
r****t@abbvie.com
-
Tim Hale
t******e@abbvie.com
-
Kumar Kantheti
Head of Customer Insights at Regeneron Pharmaceuticals, Inc.
k************i@abbvie.com
-
Alfonso Savoia
a************a@abbvie.com
-
Marie-Charlotte GOFF
m*******************f@abbvie.com
-
Carrie Strom
Senior Vice President, US Medical Aesthetics
c**********m@abbvie.com
-
Glen Curran
Vice President, Marketing, US Eyecare
g*********n@abbvie.com
-
Jessica Campagna
Director, Regulatory Affairs
j**************a@abbvie.com
-
Natalie Anderten
Director, Clinical Development Operations
n**************n@abbvie.com
-
Gamal Ferrer
Supply Planning Manager
g**********r@abbvie.com
-
Alex Selsky
a*********y@abbvie.com
-
Bill Pappano
b**********o@abbvie.com
-
Laurence Pierard
l**************d@abbvie.com
-
Jane Woo
j******o@abbvie.com
-
Liz Lloyd
l*******d@abbvie.com
-
Francescaeugenia Civardi
f**********************i@abbvie.com
-
Eric Nelson
e*********n@abbvie.com
-
Hanne Vanspaendonk
h****************k@abbvie.com
-
Jacob Degner
j**********r@abbvie.com
-
Nestor Ortiz
n**********z@abbvie.com
-
Philip Mcquain
p************n@abbvie.com
-
Tamar Uziel
t*********l@abbvie.com
-
Jill Hoeger
j*********r@abbvie.com
-
Ahmed Othman
a**********n@abbvie.com
-
Earle Bain
e********n@abbvie.com
-
Lisa Greenstein
l*************n@abbvie.com
-
Samrat Mukherjee
s**************e@abbvie.com
-
Lloyd Lam
l*******m@abbvie.com
-
Joshua Plotnik
j************k@abbvie.com
-
Stephen Fortino
s*************o@abbvie.com
-
Robert A Love
r***********e@abbvie.com
-
Tino Seidel
t*********l@abbvie.com
-
John Engelhardt
j*************t@abbvie.com
-
Mk Steel
m******l@abbvie.com
-
Carlos Taveras
c************s@abbvie.com
-
Jens Herrfurth
j************h@abbvie.com
-
Carola Vogt
c*********t@abbvie.com
-
Ariel Ting
a********g@abbvie.com
-
Anja Moeller
a**********r@abbvie.com
-
Scott Filarski
s************i@abbvie.com
-
Joachim Vogt
j**********t@abbvie.com
-
Josue Samayoa
j***********a@abbvie.com
-
Krystal Loewe
k***********e@abbvie.com
-
Jan Lohne
j*******e@abbvie.com
-
Bei Chen
b******n@abbvie.com
-
Francesca Marrani
f***************i@abbvie.com
-
Silvija Vaitkiene
s***************e@abbvie.com
-
Thorsten Pflanzner
t****************r@abbvie.com
-
Sara Orndoff
s**********f@abbvie.com
-
Antonis Papasolomontos
a********************s@abbvie.com
-
Philipp Huwe
p**********e@abbvie.com
-
Krystal Bruno
k***********o@abbvie.com
-
Lisa Miller
l*********r@abbvie.com
-
Erica Gruvberg
e************g@abbvie.com
-
Lavina Harjani
l************i@abbvie.com
-
Andrew D Vogt
a***********t@abbvie.com
-
Meri Oliva
m********a@abbvie.com
-
Mariadelcarmen Estrada
m********************a@abbvie.com
-
Elena Dianova
e***********a@abbvie.com
-
Dawn George
d*********e@abbvie.com
-
Kent Pearson
k**********n@abbvie.com
-
Kei Takatsu
k*********u@abbvie.com
-
Johannes Huelsenbeck
j******************k@abbvie.com
-
Shunya Urata
s**********a@abbvie.com
-
Sebastian Koob
s************b@abbvie.com
-
Paul E Kroeger
p************r@abbvie.com
-
Be Mnp
b****p@abbvie.com
-
Christopher Kwok
c**************k@abbvie.com
-
Brendan Mccarthysinclair
b**********************r@abbvie.com
-
Margaret Fettiskoenders
m*********************s@abbvie.com
-
Pv Saudiarabia
p************a@abbvie.com
-
Carleigh Kmetz
c************z@abbvie.com
-
Ed Reilly
e*******y@abbvie.com
-
Cyril Ramathal
c************l@abbvie.com
-
Xin X Lu
x******u@abbvie.com
-
Adrian Hobson
a***********n@abbvie.com
-
Jason Holbert
j***********t@abbvie.com
-
Susan Bale
s********e@abbvie.com
-
Cynthia Waseity
c*************y@abbvie.com
-
Michal Roszkowski
m***************i@abbvie.com
-
Mike Dennis
m*********s@abbvie.com
-
Robert Grundman
r*************n@abbvie.com
-
Sebastian Wachtarz
s****************z@abbvie.com
-
Michael R Robinson
m****************n@abbvie.com
-
Mansour Dughbaj
m*************j@abbvie.com
-
Yixin Fang
y********g@abbvie.com
-
Lisa Hazelwood
l************d@abbvie.com
-
Hannah Palac
h**********c@abbvie.com
-
Yu Deng
y*****g@abbvie.com
-
Elizabeth Shea
e************a@abbvie.com
-
Sarah Beck
s********k@abbvie.com
-
Natalie Bennett
n*************t@abbvie.com
-
Cheryl Pitcher
c************r@abbvie.com
-
Joanna Jones
j**********s@abbvie.com
-
Nancy Sever
n*********r@abbvie.com
-
Kim Hogan
k*******n@abbvie.com
-
David Maag
d********g@abbvie.com
-
Hetal Sarvaiya
h************a@abbvie.com
-
Yuki Koshi
y********i@abbvie.com
-
Stevan W Djuric
s*************c@abbvie.com
-
Hiroki Matsuo
h***********o@abbvie.com
-
Martha Titler
m***********r@abbvie.com
-
Alexandra Smith
a*************h@abbvie.com
-
Lauren Himmel
l***********l@abbvie.com
-
Forrest Weghorst
f**************t@abbvie.com
-
Nakesha Spellman
n**************n@abbvie.com
-
Parul Singh
p*********h@abbvie.com
-
Isheeta Shah
i**********h@abbvie.com
-
Christian Sanandres
c*****************s@abbvie.com
-
Anil Vasudevan
a************n@abbvie.com
-
Justin Rayyan
j***********n@abbvie.com
-
James Marek
j*********k@abbvie.com
-
Sophee Blanthornhazell
s********************l@abbvie.com
-
Rahul Mehta
r*********a@abbvie.com
-
Javier Leaniz
j***********z@abbvie.com
-
Jit Bhowmick
j**********k@abbvie.com
-
David Masica
d**********a@abbvie.com
-
Robert Mclaughlin
r***************n@abbvie.com
-
Anuj Verma
a********a@abbvie.com
-
Jianzhen Chan
j***********n@abbvie.com
-
Stephanie Weinstein
s*****************n@abbvie.com
-
Brian C Anderson
b**************n@abbvie.com
-
Karol Charkiewicz
k***************z@abbvie.com
-
Shawn Jeffries
s************s@abbvie.com
-
Stacy Sullivan
s************n@abbvie.com
-
Geoff Gz Zhang
g************g@abbvie.com
-
Namita Tundia
n***********a@abbvie.com
-
Sarah Doupe
s*********e@abbvie.com
-
Chris Medina
c**********a@abbvie.com
-
Takafumi Tanaka
t*************a@abbvie.com
-
Razaq Salau
r*********u@abbvie.com
-
Chelsea Parrocha
c**************a@abbvie.com
-
Jane Qian
j*******n@abbvie.com
-
Bryan Rogers
b**********s@abbvie.com
-
Michael Kaltschmidt
m*****************t@abbvie.com
-
Jeroen Schrevens
j**************s@abbvie.com
-
Jamie Chouinard
j*************d@abbvie.com
-
Jeffrey Waite
j***********e@abbvie.com
-
Jason Hart
j********t@abbvie.com
-
Jules Holland
j***********d@abbvie.com
-
Melvin Munsaka
m************a@abbvie.com
-
Namjin Chung
n**********g@abbvie.com
-
Ning Sun
n******n@abbvie.com
-
Edward Ronan
e**********n@abbvie.com
-
Niharika Chauhan
n**************n@abbvie.com
-
Lin Zhu
l*****u@abbvie.com
-
Anna Levi
a*******i@abbvie.com
-
Giuliana Gualberti
g****************i@abbvie.com
-
Naoki Wasa
n********a@abbvie.com
-
Zoltan Dezso
z**********o@abbvie.com
-
Reyhaneh Nazarian
r***************n@abbvie.com
-
Nam Bui
n*****i@abbvie.com
-
Dalila Miele
d**********e@abbvie.com
-
Keturah Kiper
k***********r@abbvie.com
-
Andrella King
a***********g@abbvie.com
-
Sana Khajehpour
s*************r@abbvie.com
-
Rebecca Kattan
r************n@abbvie.com
-
Jerry Jacob
j*********b@abbvie.com
-
Heather Huang
h***********g@abbvie.com
-
Catherine Ho
c**********o@abbvie.com
-
Melanie Flores
m************s@abbvie.com
-
Payal Bhatt
p*********t@abbvie.com
-
Laura Gasparini
l*************i@abbvie.com
-
Kartik Anne
k*********e@abbvie.com
-
Minna Abdelaziz
m*************z@abbvie.com
-
Josette Hughes
j************s@abbvie.com
-
Megan Jimerson
m************n@abbvie.com
-
Teresa K Oberlander
t*****************r@abbvie.com
-
Roland Heym
r*********m@abbvie.com
-
Aoi Kurano
a********o@abbvie.com
-
Jeff Onyskiw
j**********w@abbvie.com
-
Jodi Walker
j*********r@abbvie.com
-
Evgenyi Shalaev
e*************v@abbvie.com
-
Yunzhao Xing
y**********g@abbvie.com
-
Aparna Shinde
a***********e@abbvie.com
-
Leonie Hammer
l***********r@abbvie.com
-
Gregory Willocq
g*************q@abbvie.com
-
Bobbi Wiggins
b***********s@abbvie.com
-
Yoosook Kim
y*********m@abbvie.com
-
John Torrisi
j**********i@abbvie.com
-
Barbara Razenberg
b***************g@abbvie.com
-
Matthew Galley
m************y@abbvie.com
-
Emily King
e********g@abbvie.com
-
Gentry Lassiter
g*************r@abbvie.com
-
Elena Karpilovski
e***************i@abbvie.com
-
Liz Shea
l******a@abbvie.com
-
Ilke Limoncu
i**********u@abbvie.com
-
Alyssa Rege
a*********e@abbvie.com
-
Raquel Powers
r***********s@abbvie.com
-
Jeremy Picard
j***********d@abbvie.com
-
Adelle Infante
a************e@abbvie.com
-
Todd Bosse
t********e@abbvie.com
-
Joao N Belo
j*********o@abbvie.com
-
Jaquelin Finley
j*************y@abbvie.com
-
Gerlinde Baldauf
g**************f@abbvie.com
-
V Siparis
v*******s@abbvie.com
-
Jenna Hanson
j**********n@abbvie.com
-
David Wagner
d**********r@abbvie.com
-
Isabelle Petatthiolas
i*******************s@abbvie.com
-
Anisha Manix
a**********x@abbvie.com
-
Jacqueline Karis
j**************s@abbvie.com
-
Suzanne Barston
s*************n@abbvie.com
-
Shannelle Fowler
s**************r@abbvie.com
-
Dana Harville
d***********e@abbvie.com
-
Gabrielle Tarbert
g***************t@abbvie.com
-
Susanne Griffiths
s***************s@abbvie.com
-
Larry Peepo
l*********o@abbvie.com
-
Gregory Miley
g***********y@abbvie.com
-
Courtney Fella
c************a@abbvie.com
-
Jonathan Anderson
j***************n@abbvie.com
-
Jenina Nunez
j**********z@abbvie.com
-
Moiz Diwan
m********n@abbvie.com
-
Tym Lindsey
t*********y@abbvie.com
-
Office At
o*******t@abbvie.com
-
Mandie Judy
m*********y@abbvie.com
-
Fabio Lievano
f***********o@abbvie.com
-
Thao T Doan
t*********n@abbvie.com
-
Peter Bacher
p**********r@abbvie.com
-
Birgitta Bjornek
b**************k@abbvie.com
-
Joy Jacksonguilford
j******************d@abbvie.com
-
Rebecca Kohnken
r*************n@abbvie.com
-
Elizabeth Simms
e*************s@abbvie.com
-
Lucas Chavira
l***********a@abbvie.com
-
David Gardner
d***********r@abbvie.com
-
Juliapaige Yuhase
j***************e@abbvie.com
-
Fernando Bastos
f*************s@abbvie.com
-
Yunhao Tan
y********n@abbvie.com
-
Hongjian Zhu
h**********u@abbvie.com
-
Carlos Hader
c**********r@abbvie.com
-
Samira Mawla
s**********a@abbvie.com
-
Fabian Liboschik
f**************k@abbvie.com
-
Petra Grossmann
p*************n@abbvie.com
-
Anna Samokhvalova
a***************a@abbvie.com
-
Dai Feng
d******g@abbvie.com
-
Iain Boomer
i*********r@abbvie.com
-
Alice Chan
a********n@abbvie.com
-
Megana Vatson
m***********n@abbvie.com
-
Amanda Vogel
a**********l@abbvie.com
-
Jun Yu
j****u@abbvie.com
-
Kevin Zowaski
k***********i@abbvie.com
-
Eva Sebestova
e***********a@abbvie.com
-
Kathrin Kuntz
k***********z@abbvie.com
-
Brian Martin
b**********n@abbvie.com
-
Jijie Gu
j******u@abbvie.com
-
Andrew Shaw
a*********w@abbvie.com
-
Florian Dieckmann
f***************n@abbvie.com
-
David Freundel
d************l@abbvie.com
-
Javier Boix
j*********x@abbvie.com
-
Tamer Hanna
t*********a@abbvie.com
-
Diana L Donnellyroberts
d**********************s@abbvie.com
-
Dayoung Yi
d********i@abbvie.com
-
Renee Heuser
r**********r@abbvie.com
-
Blai Coll
b*******l@abbvie.com
-
Muriel Haraoui
m************i@abbvie.com
-
Daniela Haertel
d*************l@abbvie.com
-
Sanjay Bhardwaj
s*************j@abbvie.com
-
Kaisa Raitio
k**********o@abbvie.com
-
Sabine Grote
s**********e@abbvie.com
-
Johanna Castrillon
j****************n@abbvie.com
-
Veronique Paula
v*************a@abbvie.com
-
Christina Lee
c***********e@abbvie.com
-
Gary Chiang
g*********g@abbvie.com
-
Marketta Piskonen
m***************n@abbvie.com
-
Aman Thukral
a**********l@abbvie.com
-
Julie Lepsetz
j***********z@abbvie.com
-
Hannah Martinez
h*************z@abbvie.com
-
Aris Vasilopoulos
a***************s@abbvie.com
-
Ryota Watanabe
r************e@abbvie.com
-
Takao Nito
t********o@abbvie.com
-
Weili He
w******e@abbvie.com
-
Mabel Martinez
m************z@abbvie.com
-
Devin Slagle
d**********e@abbvie.com
-
Eileen Murphy
e***********y@abbvie.com
-
Giuseppina Zarigno
g****************o@abbvie.com
-
Eric Mohler
e*********r@abbvie.com
-
Min Zhang
m*******g@abbvie.com
-
Terhi Pellinen
t************n@abbvie.com
-
Anne Lejon
a********n@abbvie.com
-
Marcello Rinaldi
m**************i@abbvie.com
-
Ryoichi Kiyohara
r**************a@abbvie.com
-
Jillian Griffin
j*************n@abbvie.com
-
Shuai Hao
s*******o@abbvie.com
-
Jessica Feltman
j*************n@abbvie.com
-
Jeffrey Allan
j***********n@abbvie.com
-
Frank Benenati
f************i@abbvie.com
-
Shashank Shekhar
s**************r@abbvie.com
-
Roxann Stubbs
r***********s@abbvie.com
-
Medha Tomlinson
m*************n@abbvie.com
-
Beatriz Samanes
b*************s@abbvie.com
-
Kate Ferrario
k***********o@abbvie.com
-
Nicole Muraca
n***********a@abbvie.com
-
Jay Lucas
j*******s@abbvie.com
-
Helene Villeneuve
h***************e@abbvie.com
-
Pascal Marcoux
p************x@abbvie.com
-
Nathalie Lavoie
n*************e@abbvie.com
-
Theresia Bredenwall
t*****************l@abbvie.com
-
Ric A. Gonzalez
Chairman of the Board & Chief Executive Officer
r************z@abbvie.com
-
Vijay Raghavan
Associate Vice President, Marketing Analytics & Business Insights
v***y@abbvie.com
-
Sanjay Nilapwar
Principal Scientist
s****y@abbvie.com
-
S Nikhil Kumar
Founder
s*******r@abbvie.com
-
Tariq Ghayur
Distinguished Research Fellow
t***q@abbvie.com
-
Axel Arosenius
Psychiatry Specialty Representative
a**l@abbvie.com
-
James Holdsworth
Architect, Technology II
j***s@abbvie.com
-
Arminda Montero
Program Manager, Global Supply Chain QA
a*****a@abbvie.com
-
Customer Service
customerservice@abbvie.com
-
Unclassified inbox
talentacquisition@abbvie.com
-
Unclassified inbox
AbbvieCDO@abbvie.com
-
Unclassified inbox
privacydsr@abbvie.com
-
Unclassified inbox
info-cz@abbvie.com
-
Unclassified inbox
abbviemediarelations@abbvie.com
-
Unclassified inbox
switzerland@abbvie.com
-
Unclassified inbox
orders@abbvie.com
-
Unclassified inbox
medical_info_spain@abbvie.com
-
Unclassified inbox
safety-cz@abbvie.com
-
Unclassified inbox
plsproductsurveillanceteam@abbvie.com
-
Unclassified inbox
hrconnect.northamerica@abbvie.com
-
Unclassified inbox
abbviepaa@abbvie.com
-
Unclassified inbox
managepd_support_it@abbvie.com
-
Unclassified inbox
library@abbvie.com
-
Unclassified inbox
job-opportunities@abbvie.com
-
Unclassified inbox
sp-assuntos_regulatorios@abbvie.com
-
Unclassified inbox
cs-germany@abbvie.com
-
Customer Service
service@abbvie.com
-
Unclassified inbox
info.de@abbvie.com
-
Unclassified inbox
alan.rubin@abbvie.com
-
Unclassified inbox
adeline.teo@abbvie.com
-
Unclassified inbox
melanie.cohen@abbvie.com
-
Unclassified inbox
nancy.vangeys@abbvie.com
-
Unclassified inbox
china_pv@abbvie.com
Pfizer Venture Investments
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
50 Emails
0 Phones
Main email format: sarah.smith@pfizer.com (92.7%)
-
Rebecca Hamm
Senior Director, Communications
r**********m@pfizer.com
-
Christopher Conner
US Field Medical Excellence Vaccines + Antivirals
c****************r@pfizer.com
-
Adam Guhle
Oncology Category Lead
a********e@pfizer.com
-
Neil Campbell
Senior Director, Pfizer Global Supply
n***********l@pfizer.com
-
Mathieu Poirier
Therapeutic Area Lead, Global Commercial Access Partnerships
m*************r@pfizer.com
-
Jennifer Lafontaine
VP, Head of Oncology Medicinal Chemistry
j*****************e@pfizer.com
-
Mike Mcdermott
Chief Global Supply Officer, Executive Vice President
m************t@pfizer.com
-
Sally Susman
Executive Vice President and Chief Corporate Affairs Officer
s**********n@pfizer.com
-
Kathrin Jansen
Senior Vice President and Head of Vaccine R&D
k************n@pfizer.com
-
Paul Fitzgerald
Energy, Utilities and Facilities Services Lead
p*************d@pfizer.com
-
Julie Jenson
Director Corporate Responsibility
j***********n@pfizer.com
-
Suzanna Ladas
Source to Contract Operations
s***********s@pfizer.com
-
David Breen
Site Leader, Algete, Madrid, Spain
d*********n@pfizer.com
-
Alfredo Linares
Vice President, People Experience, Organizational Development and Communications, PGS Division
a*************s@pfizer.com
-
Nooshin Rahimi
Professional Healthcare Representative
n************i@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
p****u@pfizer.com
-
Andrew Nager
a**********r@pfizer.com
-
Chikita Sobti
c***********i@pfizer.com
-
Professionalerika Schremp
p***********************p@pfizer.com
-
Unclassified inbox
samuel.thevasagayam@pfizer.com
-
General Inquiries
alfredo.chi@pfizer.com
-
Unclassified inbox
andrew.nager@pfizer.com
-
Unclassified inbox
chikita.sobti@pfizer.com
-
Unclassified inbox
professionalerika.schremp@pfizer.com
Merck
Merck is a biopharmaceutical company that offers mShow more...edicines and vaccines for various diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
49 Emails
0 Phones
Main email format: sarah_smith@merck.com (75.0%)
-
Phillip Samayoa
Associate Director, MRL Ventures
p******s@merck.com
-
Joseph Schaller
j*************r@merck.com
-
Joseph Schaller
j*************r@merck.com
-
Eliav Barr
Vice President, Infectious Diseases
e********r@merck.com
-
Peter Honigmann
p*************n@merck.com
-
Rob Davis
r*******s@merck.com
-
Dean Li
Senior Vice President of Discovery Sciences and Translational Medicine
d*****i@merck.com
-
Dean Li
Senior Vice President of Discovery Sciences and Translational Medicine
d****i@merck.com
-
Renee Suhr
r********r@merck.com
-
Caroline Litchfield
c*****************d@merck.com
-
Todd Herman
t*********n@merck.com
-
Todd Herman
t*********n@merck.com
-
Eunkyung Kauh
e***********h@merck.com
-
Cameron Downie
c************e@merck.com
-
Cameron Downie
c************e@merck.com
-
Martin Khun
m*********n@merck.com
-
Martin Khun
m*********n@merck.com
-
Joe Volpe
j**********e@merck.com
-
Lubomir Kamensky
l**************y@merck.com
-
Carolina Colella
c**************a@merck.com
-
Rachel Parise
PhD Candidate - Analytical Chemistry Reseacher
r***********e@merck.com
-
Peter Dudek
Associate
p*********k@merck.com
-
Marc Gailhardou
a VP Global Oncology Strategy at Merck
m*************u@merck.com
-
Jieyun Hao
HR Business Partner
j********o@merck.com
-
Francesca Poggio
f**************o@merck.com
-
Ken Friesen
k*********n@merck.com
-
Austin Snook
a**********k@merck.com
-
Roberta Corsi
r***********i@merck.com
-
Vishal Sahni
Venture Capital advisory committee member, Biofund II
v**********i@merck.com
-
John Minehane
Assistant Production Manager
j***********e@merck.com
-
Cheryl Donnelly
c*************y@merck.com
-
Courtney Ronaldo
c**************o@merck.com
-
Tracy Clemmer
t************2@merck.com
-
Harry Herar
Sales Representative
h*********r@merck.com
-
Andrei Manica
a***********a@merck.com
-
Sergey Zverev
s***********v@merck.com
-
Rehan A Khan
r********n@merck.com
-
Kevin Ali
k*******i@merck.com
-
Kevin Sharpe
k**********e@merck.com
-
Heather Rakestraw
h***************w@merck.com
-
Cedric Grand-Pierre
c****************e@merck.com
-
Joyce. Pennings
j************s@merck.com
-
Anneke Rietveld
Key Account Manager
a*************d@merck.com
-
Kathleen Cuddy
k************y@merck.com
-
Unclassified inbox
estanislao_meza@merck.com
-
Unclassified inbox
alain_boisvert@merck.com
-
Unclassified inbox
retailteam@merck.com
-
Unclassified inbox
rgball@merck.com
-
Unclassified inbox
kathleen.cuddy@merck.com
Pfizer
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 9, 2024
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
42 Emails
0 Phones
Main email format: sarah.smith@pfizer.com (92.1%)
-
Rebecca Hamm
Senior Director, Communications
r**********m@pfizer.com
-
Christopher Conner
US Field Medical Excellence Vaccines + Antivirals
c****************r@pfizer.com
-
Adam Guhle
Oncology Category Lead
a********e@pfizer.com
-
Neil Campbell
Senior Director, Pfizer Global Supply
n***********l@pfizer.com
-
Mathieu Poirier
Therapeutic Area Lead, Global Commercial Access Partnerships
m*************r@pfizer.com
-
Jennifer Lafontaine
VP, Head of Oncology Medicinal Chemistry
j*****************e@pfizer.com
-
Mike Mcdermott
Chief Global Supply Officer, Executive Vice President
m************t@pfizer.com
-
Sally Susman
Executive Vice President and Chief Corporate Affairs Officer
s**********n@pfizer.com
-
Kathrin Jansen
Senior Vice President and Head of Vaccine R&D
k************n@pfizer.com
-
Paul Fitzgerald
Energy, Utilities and Facilities Services Lead
p*************d@pfizer.com
-
Julie Jenson
Director Corporate Responsibility
j***********n@pfizer.com
-
Suzanna Ladas
Source to Contract Operations
s***********s@pfizer.com
-
David Breen
Site Leader, Algete, Madrid, Spain
d*********n@pfizer.com
-
Alfredo Linares
Vice President, People Experience, Organizational Development and Communications, PGS Division
a*************s@pfizer.com
-
Nooshin Rahimi
Professional Healthcare Representative
n************i@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com
Novo Nordisk
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
49 Emails
0 Phones
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Tony Woolard
Supervisor, Operations
t**y@novonordisk.com
-
Kasper Tarp Mortensen
Manager of Medical Affairs Excellence
k*m@novonordisk.com
-
Betina Woythal
Vice President, EA to SVP of CMC Development
b*o@novonordisk.com
-
Thomas Senderovitz
Senior Vice President Data Science
t****s@novonordisk.com
-
Liselotte Hyveled
Project Vice President, Insulin and Device
l*y@novonordisk.com
-
Steve Albers
Executive Director, Market Access
s**r@novonordisk.com
-
Jesper Hahne
Finance Partner
j**h@novonordisk.com
-
Daniel Timmermann
Head of Innovation, Global Drug Discovery
d****l@novonordisk.com
-
Jesper Lau
vice president
j**a@novonordisk.com
-
Anders Holm Mikkelsen
Head of Business Partnering Strategy Execution
a**x@novonordisk.com
-
Susan Ames
Specialist- IT Training & Communication
s**s@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com
-
Unclassified inbox
ldad@novonordisk.com
-
Unclassified inbox
myce@novonordisk.com
-
Unclassified inbox
mtwg@novonordisk.com
-
Unclassified inbox
kbjo@novonordisk.com
-
Unclassified inbox
zast@novonordisk.com
Novo Nordisk
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Aug 30, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
44 Emails
0 Phones
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Tony Woolard
Supervisor, Operations
t**y@novonordisk.com
-
Kasper Tarp Mortensen
Manager of Medical Affairs Excellence
k*m@novonordisk.com
-
Betina Woythal
Vice President, EA to SVP of CMC Development
b*o@novonordisk.com
-
Thomas Senderovitz
Senior Vice President Data Science
t****s@novonordisk.com
-
Liselotte Hyveled
Project Vice President, Insulin and Device
l*y@novonordisk.com
-
Steve Albers
Executive Director, Market Access
s**r@novonordisk.com
-
Jesper Hahne
Finance Partner
j**h@novonordisk.com
-
Daniel Timmermann
Head of Innovation, Global Drug Discovery
d****l@novonordisk.com
-
Jesper Lau
vice president
j**a@novonordisk.com
-
Anders Holm Mikkelsen
Head of Business Partnering Strategy Execution
a**x@novonordisk.com
-
Susan Ames
Specialist- IT Training & Communication
s**s@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com
Gilead Sciences
Gilead Sciences is a biopharmaceutical company thaShow more...t discovers, develops, manufactures and commercializes therapies for critical diseases.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: Jun 22, 1987
Number of Exits: 16
Company Type: For Profit
Stock Symbol: BIT:GILD
Operating Status: Active
34 Emails
0 Phones
Main email format: sarah.smith@gilead.com (53.6%)
-
Ahmed Afifi
Vice President - Region Head Latin America
a*********i@gilead.com
-
Kelsey Reedy
Talent Advisor
k**********y@gilead.com
-
Anhquan Nguyen
Senior Research Associate
a*****n@gilead.com
-
Jack Wessel
Associate General Counsel, IP
j*********l@gilead.com
-
Patrick Loerch
Senior Vice President, Clinical Data Science
p*****h@gilead.com
-
Rashad Burgess
Regional Sales Director
r************s@gilead.com
-
Brian Peters
Senior Director, Procurement
f*****n@gilead.com
-
Don Dennis
Director
d********s@gilead.com
-
Elysia K
Sr. Clinical Trial Management Associate
e******k@gilead.com
-
Merdad Parsey
EVP & CMO Gilead Sciences
m*****y@gilead.com
-
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing,
m**********h@gilead.com
-
Ketki Malgaonkar
Regulatory Affairs Manager
k**************r@gilead.com
-
Abhishek Bachchan
a***************n@gilead.com
-
Yin Jonkman
Compensation and Benefits Manager EMEA a.i
y*********n@gilead.com
-
Ethan Grant
e*********t@gilead.com
-
Karim Lee
k*******e@gilead.com
-
Angie Hertz
a*********z@gilead.com
-
Fatima Farid
f**********d@gilead.com
-
Nara Ramakrishnan
n***************n@gilead.com
-
Alexis Mehta6
a***********6@gilead.com
-
Gary Tully
Head of Legal Operations
g**y@gilead.com
-
Joel Bercu
Associate Director
j****u@gilead.com
-
Teresa Wang
Director, Investor Relations
w**g@gilead.com
-
Daniel O'Day
Chairman and Chief Executive Officer
d****l@gilead.com
-
Jacopo Andreose
SVP Intercontinental and Global Patient Solutions
j****o@gilead.com
-
Michael L. Riordan
Founder
m***************n@gilead.com
-
Mark Hill
Senior Vice President & CIO
m**k@gilead.com
-
Wenjun Ouyang
Senior Vice President
w****n@gilead.com
-
Anthony Mire-Sluis
Senior Vice President Quality
a**********s@gilead.com
-
Bob Mecca
Senior Vice President Finance
b*b@gilead.com
-
Unclassified inbox
public_affairs@gilead.com
-
Unclassified inbox
bernard.murray@gilead.com
-
Unclassified inbox
andre.luescher@gilead.com
-
Unclassified inbox
20careers@gilead.com
Bayer
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
35 Emails
0 Phones
Main email format: sarah.smith@bayer.com (100.0%)
-
Annick D'haese
MA
a***********e@bayer.com
-
Christopher Yeechan
Associate Director Procurement - API & Raw Materials
c*****************n@bayer.com
-
Christian Lauterbach
Europe Region 1
c******************h@bayer.com
-
Bob Reiter
Head of Research & Development, Crop Science
b********r@bayer.com
-
Nick Canner
Executive Sales Consultant - Dermatology
n*********r@bayer.com
-
Bill Anderson
CEO-elect
b***********n@bayer.com
-
Aida Baban
Head Medical Information & Governance, Medical Affairs, Bayer Vital
a********n@bayer.com
-
Dr. Stephanie Schermuck-Joschko
Global Strategic Marketing Director
s*************************o@bayer.com
-
Joris Schreurs
Pharmacovigilance Officer
j************s@bayer.com
-
Mario Repetto
Agente Propaganda Médica
m***********o@bayer.com
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
Joachim Hoechel
j*************l@bayer.com
-
Chikako Takayama
c**************a@bayer.com
-
Kumiko Tanabe
k***********e@bayer.com
-
General Inquiries
info@bayer.com
-
Unclassified inbox
olaf.zoellner.b@bayer.com
-
Unclassified inbox
salvador.llado@bayer.com
-
Unclassified inbox
joachim.hoechel@bayer.com
-
Unclassified inbox
chikako.takayama@bayer.com
-
Unclassified inbox
kumiko.tanabe@bayer.com
Roche
Roche is a pharmaceutical and diagnostics company Show more...that focuses on improving people’s lives.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: Jan 15, 1896
Number of Exits: 3
Company Type: For Profit
Stock Symbol: SWX:ROG
Operating Status: Active
36 Emails
0 Phones
Main email format: sarah.smith@roche.com (100.0%)
-
Jason Hall
Senior Business Analyst
j********l@roche.com
-
Thomas Schinecker
t***************r@roche.com
-
Brad Moore
b********e@roche.com
-
Andre Hoffmann
a************n@roche.com
-
Darla Ramsey
d**********p@roche.com
-
Kevin Bylinski
k************i@roche.com
-
Abed Sabra
a********a@roche.com
-
Nikolce Gjorevski
n***************i@roche.com
-
David Barton
d********1@roche.com
-
Mark Adam
m*******m@roche.com
-
Andrzej Dobrowolski
a*****************i@roche.com
-
Tristin Martin
t************n@roche.com
-
Ivana Vodopivec
i*************c@roche.com
-
William Fraser
w************r@roche.com
-
Björn Itrich
b*********h@roche.com
-
Martin Erschbamer
m***************r@roche.com
-
Anand Vairavan
a************n@roche.com
-
Tim Kuruvilla
Investment Associate
t***********a@roche.com
-
Sanju Sudhakar
s************r@roche.com
-
Szymon Arkuszewski
s****************i@roche.com
-
Mattia Giobbi
m***********i@roche.com
-
Krzysztof Wisniewski
k******************i@roche.com
-
Judy Ney
j******y@roche.com
-
Nancy Yuan
n********n@roche.com
-
Kadir Demirtas
k************s@roche.com
-
Thierry Lave
Global Head DMPK and TOX Project Leaders and Modeling and Simulation
t**********e@roche.com
-
Unclassified inbox
patientcare@roche.com
-
Unclassified inbox
new_zealand.dia_communications@roche.com
-
Unclassified inbox
ireland.drug_surveillance_centre@roche.com
-
General Inquiries
illovo.medinfo@roche.com
-
Unclassified inbox
joerg.kazenwadel@roche.com
-
Unclassified inbox
klaus.christensen@roche.com
-
General Inquiries
mississauga.canada_medinfo@roche.com
-
Unclassified inbox
jana.vichova@roche.com
-
Unclassified inbox
antonio.cruz@roche.com
-
Unclassified inbox
ns@roche.com
AstraZeneca
AstraZeneca is a pharmaceutical company that discoShow more...vers, develops, manufactures, and markets prescription medicines.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active
32 Emails
0 Phones
Main email format: sarah.smith@astrazeneca.com (100.0%)
-
Marc Dunoyer
Chief Strategy Officer
m**********r@astrazeneca.com
-
Richard Gallo
Oncology Contract Strategy Manager
r***********o@astrazeneca.com
-
Nabil Dharsi
Medical Science Liaison, Hematology
n**********i@astrazeneca.com
-
Dan Wygal
Executive Director of Contract and Channel Strategy
d*******l@astrazeneca.com
-
Claudia Lamp
Contract Sr Patient Safety Scientist
c**********p@astrazeneca.com
-
Tom Keith-Roach
President, Astrazeneca UK
t*************h@astrazeneca.com
-
Mary Richardson
Global Publications Director, OBU
m*************n@astrazeneca.com
-
Matthew Roe
VP, Head of Early Clinical Development - Cardiovascular, Renal, and Metabolic
m*********e@astrazeneca.com
-
Jennifer Schmoll
Global Marketing Director-Diabetes
j**************l@astrazeneca.com
-
Lee Bennett
Associate Regulatory Project Director
l*********t@astrazeneca.com
-
Jasmine Jansens
Clinical Site Monitor
j*************s@astrazeneca.com
-
Stephanie Kenney
Global Head of Corporate Affairs, Cardiovascular Renal and Metabolism
s********************i@astrazeneca.com
-
Giovanni Melillo
Vice President - Immuno-oncology, Global Medical Affairs
g**************o@astrazeneca.com
-
Karina Estevez
Human Resources Global Graduate Associate
k************z@astrazeneca.com
-
Francesco Dazzi
Professor of Regenerative and Haematological Medicine - KHP Lead for Cellular Therapies
f*************i@astrazeneca.com
-
Graham Belfield
g*************d@astrazeneca.com
-
Tony Pusic
t********c@astrazeneca.com
-
Ronnie Stevens
r************s@astrazeneca.com
-
Miriam Wu
m*******u@astrazeneca.com
-
James Thomas Coates
Principal
j**********s@astrazeneca.com
-
Chandler Chen
Investment Director, Healthcare Fund
c***********n@astrazeneca.com
-
Jelena Saillard
j*************d@astrazeneca.com
-
Debasree Purkayastha
d******************a@astrazeneca.com
-
Shameen Afif-Rider
s****************r@astrazeneca.com
-
Wilbur Washington
Oncology Senior Sales Specialist - Hematology/Solid Tumor
w***************n@astrazeneca.com
-
David Bock
d********k@astrazeneca.com
-
General Inquiries
contact@astrazeneca.com
-
General Inquiries
help@astrazeneca.com
-
General Inquiries
takemi.sunouchi@astrazeneca.com
-
Unclassified inbox
astrazeneca.india@astrazeneca.com
-
Unclassified inbox
opsmexicoprocurement@astrazeneca.com
-
Unclassified inbox
speakerprogramsmailbox@astrazeneca.com
Bayer
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@bayer.com (100.0%)
-
Annick D'haese
MA
a***********e@bayer.com
-
Christopher Yeechan
Associate Director Procurement - API & Raw Materials
c*****************n@bayer.com
-
Christian Lauterbach
Europe Region 1
c******************h@bayer.com
-
Bob Reiter
Head of Research & Development, Crop Science
b********r@bayer.com
-
Nick Canner
Executive Sales Consultant - Dermatology
n*********r@bayer.com
-
Bill Anderson
CEO-elect
b***********n@bayer.com
-
Aida Baban
Head Medical Information & Governance, Medical Affairs, Bayer Vital
a********n@bayer.com
-
Dr. Stephanie Schermuck-Joschko
Global Strategic Marketing Director
s*************************o@bayer.com
-
Joris Schreurs
Pharmacovigilance Officer
j************s@bayer.com
-
Mario Repetto
Agente Propaganda Médica
m***********o@bayer.com
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com
Bayer
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@bayer.com (100.0%)
-
Annick D'haese
MA
a***********e@bayer.com
-
Christopher Yeechan
Associate Director Procurement - API & Raw Materials
c*****************n@bayer.com
-
Christian Lauterbach
Europe Region 1
c******************h@bayer.com
-
Bob Reiter
Head of Research & Development, Crop Science
b********r@bayer.com
-
Nick Canner
Executive Sales Consultant - Dermatology
n*********r@bayer.com
-
Bill Anderson
CEO-elect
b***********n@bayer.com
-
Aida Baban
Head Medical Information & Governance, Medical Affairs, Bayer Vital
a********n@bayer.com
-
Dr. Stephanie Schermuck-Joschko
Global Strategic Marketing Director
s*************************o@bayer.com
-
Joris Schreurs
Pharmacovigilance Officer
j************s@bayer.com
-
Mario Repetto
Agente Propaganda Médica
m***********o@bayer.com
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com
Bristol-Myers Squibb
Bristol-Myers Squibb engages in the discovery, devShow more...elopment, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 28, 2024
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital
30 Emails
0 Phones
Main email format: sarah.smith@bms.com (95.5%)
-
John damonti
Foundation President
d******j@bms.com
-
Ron Behling
r************g@bms.com
-
Devin Carsdale
d************e@bms.com
-
Suketu Desai
s**********i@bms.com
-
Zelalem Demere
z************e@bms.com
-
Eva Dion
e******n@bms.com
-
Dina Akbar
d********r@bms.com
-
Jaya Saigal
j*********l@bms.com
-
Danish Sheikh
d***********h@bms.com
-
Trisha Putro
t**********o@bms.com
-
Xue Li
x****i@bms.com
-
Gianina Meltzer
Senior Manager, Regulatory Affairs (Oncology)
g*************r@bms.com
-
Zachary Cain
Associate Director, Payer Marketing at Bristol-Myers Squibb
z**********n@bms.com
-
Zheng Yang
Scientist
z********g@bms.com
-
Herve Bertacchi
h*************i@bms.com
-
Ming Lu
Vice President Clinical Pharmacology
m*****u@bms.com
-
Sonja Heintz
s**********z@bms.com
-
Torsten Schanze
t*************e@bms.com
-
Patricia Gaul
p***********l@bms.com
-
Vanessa Mariani
v****************a@bms.com
-
Emmanuel Chantelot
e****************t@bms.com
-
Ha Dang
h*****g@bms.com
-
Maribelis Ruiz
m************z@bms.com
-
Sanna Viitanen
s************n@bms.com
-
Unclassified inbox
drugsafety@celgene.com
-
Unclassified inbox
carmen.m.lopez@bms.com
-
Unclassified inbox
eduardo.uribe@bms.com
-
Unclassified inbox
sanna.viitanen@bms.com
-
Unclassified inbox
bd-onchema@bms.com
-
Unclassified inbox
bd-ct@bms.com
Johnson Matthey
Johnson Matthey is an international speciality cheShow more...micals company, founded almost 200 years ago in London.
Specialized In: Manufacturing & Industrial, Technology & Software, Pharmaceuticals, Staffing Agencies
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 20, 2024
Founded Date: 1817
Number of Exits: 1
Company Type: For Profit
Stock Symbol: LSE:JMPLF
Operating Status: Active
31 Emails
0 Phones
Main email format: sarah.smith@matthey.com (90.0%)
-
Margaret Ruiseal
Global HR Transformation Director
m**************l@matthey.com
-
Erwin Teirlinck
Business Development Manager
e*************k@matthey.com
-
Kendra Briggs
Sales Manager
k*********g@matthey.com
-
Anca Faur
Program Manager, Fuel Cells
a*******r@matthey.com
-
Janet Lung Standing
Global Procurement Director - Indirects
j************g@matthey.com
-
Emilie Pijls
Director Global Procurement - Sector Clean Air
e**********s@matthey.com
-
Akshay Kolte
Program Manager
a**********e@matthey.com
-
Florin Filipas
Sr. Process Engineer
f************s@matthey.com
-
David Colomina
ITIL Instructor
d************a@matthey.com
-
Sharmila Thirumalai
Technical Recruiter
s*****************i@matthey.com
-
Ekaterina Novakova
Market Manager Purification
e****************a@matthey.com
-
Aaron Bloomfield
Research And Development Scientist
a**************d@matthey.com
-
Rebecca Lawman
Marketing Director
r************n@matthey.com
-
David Nguyen
Human-centered Innovator/Entrepreneur/Researcher
n*****d@matthey.com
-
Ryan Mitstifer
Global Operational Excellence Leader
r************r@matthey.com
-
Jonathan Mccreegrey
Hydrogen Technologies Recycling Manager
jm@matthey.com
-
Joe Fox
Finance Transformation Director
j*****x@matthey.com
-
Randy Lerch
Night Shift Maintenance Supervisor
r*********h@matthey.com
-
Harry Deans
EHS & Operations Officer
h*********s@matthey.com
-
Karen Hayzen-Smith
Director of Group Finance
k****************h@matthey.com
-
Benedicte Thiebaut
Technology Director of Medical Components
b****************t@matthey.com
-
Percival Norton Johnson
Founder
j*****n@matthey.com
-
Elmar Braeuning
e*************g@matthey.com
-
Unclassified inbox
elmar.braeuning@matthey.com
-
Unclassified inbox
mj@matthey.com
-
General Inquiries
group.info@matthey.com
-
Unclassified inbox
jmpr@matthey.com
-
Unclassified inbox
kristm@matthey.com
-
Unclassified inbox
jmj-catalog@matthey.com
-
Unclassified inbox
timothy.johnson@matthey.com
-
Unclassified inbox
jm-china-graduate@matthey.com
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
29 Emails
0 Phones
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Judy Kim
j******m@ucsf.edu
-
Sunita Mutha
Professor of Medicine
s**********a@ucsf.edu
-
Danilo Bernardo
d*************o@ucsf.edu
-
Fred Schaufele
f************e@ucsf.edu
-
Susanna Chau
s**********u@ucsf.edu
-
Butsina Wanjala
b*************a@ucsf.edu
-
Lori Luo
MD/PhD Student
l******o@ucsf.edu
-
Michael Lavelle
m*************e@ucsf.edu
-
Christopher Stewart
c***********t@ucsf.edu
-
Jiyong Ahn
j********n@ucsf.edu
-
Peng Cong
Professor and Director of Brain Interface Technology
p*******g@ucsf.edu
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Jenna Fields
j**********s@ucsf.edu
-
Anthony Digiorgio
a***************o@ucsf.edu
-
Judith Kunitz
j***********z@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu
-
Unclassified inbox
ucsf.msa.juma@ucsf.edu
-
Unclassified inbox
david.fernandezlopez@ucsf.edu
-
Unclassified inbox
jenna.fields@ucsf.edu
-
Unclassified inbox
anthony.digiorgio@ucsf.edu
-
Unclassified inbox
judith.kunitz@ucsf.edu
GlaxoSmithKline
GlaxoSmithKline develops and markets products in tShow more...he areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 1, 2024
Founded Date: 1929
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:GSK
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@gsk.com (94.1%)
-
Magnus Hibbert
m************t@gsk.com
-
Warren Carin
w**********n@gsk.com
-
Philip Thomson
p**************n@gsk.com
-
Fernando Bruni
f************i@gsk.com
-
Bill Sass
b*******s@gsk.com
-
Heinz Doofenshmirtz
h*****************z@gsk.com
-
Lydie Georges
l***********s@gsk.com
-
Alex Benn
a*******n@gsk.com
-
Regis Simard
r**********d@gsk.com
-
Darwin Johnston
d*************n@gsk.com
-
Warren Carin
w************n@gsk.com
-
Leigh Baker
l*********r@gsk.com
-
Jessica Beacham
j*************m@gsk.com
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
Ukirl Servicehr
u*************r@gsk.com
-
Unclassified inbox
askus@gsk.com
-
Unclassified inbox
manuel.m.bermudez@gsk.com
-
Unclassified inbox
carol_a_jennings@gsk.com
-
Human Resources Team
ukirl.servicehr@gsk.com
-
Unclassified inbox
id.cpa@gsk.com
Quintiles
Quintiles is a provider of biopharmaceutical develShow more...opment and commercial outsourcing services for drugs on the market.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Acquired by: IMS Health
Business Type: Delisted
Employees: 10001+
Rounds: Grant
Last Investment Activity: Jan 22, 2024
Founded Date: 1982
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:Q
Operating Status: Active
23 Emails
1 Phones
Main email format: sarah.smith@quintiles.com (100.0%)
-
Saida El Maslouhi, MSc.
Director Early Clinical Development
s**************i@quintiles.com
-
Darren Coish
d**********h@quintiles.com
-
Kimmy Yang
Senior Clinical Research Associate
k********g@quintiles.com
-
Priya Gamre
Assistant Medical Data Review Manager
p*********e@quintiles.com
-
Lucia Novoa
Clinical Team Leader
l*********a@quintiles.com
-
Aisha Keller
a**********r@quintiles.com
-
Brian Kelly
Senior Advisor
p************k@quintiles.com
-
Jara Soltero
j**********o@quintiles.com
-
Hicham Benhaddi
h*************i@quintiles.com
-
Alistair Grenfell
President North Europe, Middle East, Africa and South Asia
a***************l@quintiles.com
-
Diane Brescia
Sr. Recruiter
d***********a@quintiles.com
-
Parag Phad
p********d@quintiles.com
-
Michelle Wilken
Director of Commercial Strategy
m*************n@quintiles.com
-
Jeff Fusco
j********o@quintiles.com
-
Cindy Lam
c*******m@quintiles.com
-
Patrick Daly
Executive In Residence
p**********y@quintiles.com
-
Debalina Pani
d***********i@quintiles.com
-
Fatemeh Tahavori
f**************i@quintiles.com
-
Amarpreet Chawla
a**************a@quintiles.com
-
Nabeel Abdallah
n*************h@quintiles.com
-
Katarina Moulinet
k***************t@quintiles.com
-
Unclassified inbox
mallika.bhaskar@quintiles.com
-
Unclassified inbox
matthew.frese@quintiles.com
GSK
GSK manufactures pharmaceutical medicines, vaccineShow more...s, and consumer healthcare products.
Specialized In: Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 20, 2024
Founded Date: Jan 2000
Company Type: For Profit
Stock Symbol: BOM:500660
Operating Status: Active
22 Emails
0 Phones
Main email format: sarah.smith@gsk.com (93.8%)
-
Magnus Hibbert
m************t@gsk.com
-
Warren Carin
w**********n@gsk.com
-
Philip Thomson
p**************n@gsk.com
-
Fernando Bruni
f************i@gsk.com
-
Bill Sass
b*******s@gsk.com
-
Heinz Doofenshmirtz
h*****************z@gsk.com
-
Lydie Georges
l***********s@gsk.com
-
Alex Benn
a*******n@gsk.com
-
Regis Simard
r**********d@gsk.com
-
Darwin Johnston
d*************n@gsk.com
-
Warren Carin
w************n@gsk.com
-
Leigh Baker
l*********r@gsk.com
-
Jessica Beacham
j*************m@gsk.com
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
Unclassified inbox
askus@gsk.com
GSK
GSK manufactures pharmaceutical medicines, vaccineShow more...s, and consumer healthcare products.
Specialized In: Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 20, 2024
Founded Date: Jan 2000
Company Type: For Profit
Stock Symbol: BOM:500660
Operating Status: Active
22 Emails
0 Phones
Main email format: sarah.smith@gsk.com (93.8%)
-
Magnus Hibbert
m************t@gsk.com
-
Warren Carin
w**********n@gsk.com
-
Philip Thomson
p**************n@gsk.com
-
Fernando Bruni
f************i@gsk.com
-
Bill Sass
b*******s@gsk.com
-
Heinz Doofenshmirtz
h*****************z@gsk.com
-
Lydie Georges
l***********s@gsk.com
-
Alex Benn
a*******n@gsk.com
-
Regis Simard
r**********d@gsk.com
-
Darwin Johnston
d*************n@gsk.com
-
Warren Carin
w************n@gsk.com
-
Leigh Baker
l*********r@gsk.com
-
Jessica Beacham
j*************m@gsk.com
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
Unclassified inbox
askus@gsk.com
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
21 Emails
0 Phones
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Judy Kim
j******m@ucsf.edu
-
Sunita Mutha
Professor of Medicine
s**********a@ucsf.edu
-
Danilo Bernardo
d*************o@ucsf.edu
-
Fred Schaufele
f************e@ucsf.edu
-
Susanna Chau
s**********u@ucsf.edu
-
Butsina Wanjala
b*************a@ucsf.edu
-
Lori Luo
MD/PhD Student
l******o@ucsf.edu
-
Michael Lavelle
m*************e@ucsf.edu
-
Christopher Stewart
c***********t@ucsf.edu
-
Jiyong Ahn
j********n@ucsf.edu
-
Peng Cong
Professor and Director of Brain Interface Technology
p*******g@ucsf.edu
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu
Amgen
Amgen is a biotechnology company that develops andShow more... manufactures human therapeutics for various illnesses and diseases.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 21, 2024
Founded Date: 1980
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NASDAQ:AMGN
Operating Status: Active
27 Emails
0 Phones
Main email format: ssmith@amgen.com (88.9%)
-
Esteban Santos
Executive Vice President, Operations
e******s@amgen.com
-
Bob Bradway
Chief Executive Officer
b******y@amgen.com
-
Angelina Finch
Marketing Director, U.S. Value & Access
a****h@amgen.com
-
Jack Ryan
Operations Manager
j***n@amgen.com
-
Gladys Nunez
Director
g**********z@amgen.com
-
Gladys Nunez
Director
g****z@amgen.com
-
Kathrine Parrish
Patient Access and Reimbursement Manager
k******h@amgen.com
-
Chen Xiaoyue
Post doctoral research fellow in Oncology department
c******e@amgen.com
-
Rosalyn Rivera
Director, Contract Manufacturing
r*****a@amgen.com
-
Nicola Magill
Senior Manager / Principal Engineer
n*****l@amgen.com
-
Sheela Kotagiri
Project Manager
s*******i@amgen.com
-
Ingrid Darmody
Senior Associate QA
i******y@amgen.com
-
Sergio Rodriguez Mallada
QA Specialist
s******a@amgen.com
-
Wendy Kusler
w*****r@amgen.com
-
Krupali Patel
k****l@amgen.com
-
Susan Sweeney
s******y@amgen.com
-
Angelinda Chen
Gender Lens Impact Investing Fellow
a***n@amgen.com
-
Daniel Lu
d*u@amgen.com
-
Rex Atienza
r******a@amgen.com
-
Unclassified inbox
HCCIME@amgen.com
-
Unclassified inbox
medinfocanada@amgen.com
-
Unclassified inbox
amgenmediarelations@amgen.com
-
Unclassified inbox
thood@amgen.com
-
Unclassified inbox
vinsonl@amgen.com
-
Unclassified inbox
joepr@amgen.com
-
Unclassified inbox
u003ejoepr@amgen.com
-
Unclassified inbox
caring@amgen.com
Moderna
Moderna Therapeutics is a biotechnology company thShow more...at specializes in drug discovery and drug development based on messenger RNA.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 15, 2024
Founded Date: 2010
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:MRNA
Operating Status: Active
Investor Type: Investment Bank
24 Emails
0 Phones
Main email format: sarah.smith@modernatx.com (100.0%)
-
Huijuan Li
Head, Analytical Development
h********i@modernatx.com
-
Kerry Salandria
Associate Director, Analytical Operations
k*************a@modernatx.com
-
Dean Geribo
Head of Corporate Security
d*********o@modernatx.com
-
Michael Wythe
Senior Director
m***********e@modernatx.com
-
Spyros Chalkias
Senior Medical Director, Clinical Development, Infectious Disease - Public Health Vaccines
s*************s@modernatx.com
-
Galit Alter
VP of Immunology Research
g*********r@modernatx.com
-
Tina Earl
Sr. Specialist, Quality Assurance
t*******l@modernatx.com
-
Francesca Ceddia
SVP Respiratory Vaccines, Global Medical
f**************a@modernatx.com
-
Lilly Naqvi
Engineer II
l*********i@modernatx.com
-
Seymour De Picciotto
Scientific Director
s*****************o@modernatx.com
-
Tatiana Novobrantseva
Chief Scientific Officer, Immuno-Oncology Research
t*******************a@modernatx.com
-
Juan Andres
Senior Vice President Technical Development, Manufacturing and Quality
j*********s@modernatx.com
-
Juan Andres
Senior Vice President Technical Development, Manufacturing and Quality
s***********y@modernatx.com
-
Nidal El Assi
Associate Director Of Lab Operations
n********i@modernatx.com
-
Lavina Talukdar
l*************r@modernatx.com
-
Shannon Thyme Klinger
Chief Legal Officer at Moderna
s*************r@modernatx.com
-
Gamal Elfatarany
g**************y@modernatx.com
-
Kate Jeffrey
k**********y@modernatx.com
-
Katriona Methven
k**************n@modernatx.com
-
Unclassified inbox
WeCare@modernatx.com
-
Unclassified inbox
Grace.Chen@modernatx.com
-
General Inquiries
info@modernatx.com
-
Unclassified inbox
stephane.bancel@modernatx.com
-
Unclassified inbox
careers@modernatx.com
Battelle
Battelle Memorial Institute is a nonprofit researcShow more...h and development organization.
Specialized In: Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Jan 17, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: Non-profit
Operating Status: Active
24 Emails
0 Phones
Main email format: sarah@battelle.org (50.0%)
-
Cassandra Manos
Senior Contracts Manager
m*************a@bah.com
-
Joe Cochran
Aviation Security Division Manager
c******j@battelle.org
-
Tesema Chekol
Senior Research Scientist
c*****t@battelle.org
-
Alexa Konstantinos
k***********a@battelle.org
-
Anthony Mitchell
m*******a@battelle.org
-
Joseph Kola
Director, Strategy and Operational Efficiency
k***j@battelle.org
-
David White
Chief Information Officer
h*****l@battelle.org
-
Aimee Kennedy
SVP of Human Resources
a***e@battelle.org
-
Eric Richardson
Enterprise Data Architect
e**c@battelle.org
-
Edward Grecco
Executive Vice President, Chief Financial Officer
e****d@battelle.org
-
Ron Townsend
Executive Vice President, Global Laboratory Operations
r*n@battelle.org
-
Douglas Porto Silva
Senior Research Scientist
d*************a@battelle.org
-
Russell Austin
Vice President, General Counsel and Secretary
r*****l@battelle.org
-
Gordon Battelle
Founder
g****n@battelle.org
-
Paul Crane
Chief Operating Officer
p**l@battelle.org
-
Lou Von Thaer
President and Chief Executive Officer
l*********r@battelle.org
-
Michael Janus
Senior Vice President & General Manager, Environment & Infrastructure
m***********s@battelle.org
-
Daniel Pikora
Senior Vice President / General Manager - National Security
d****l@battelle.org
-
Unclassified inbox
solutions@battelle.org
-
Unclassified inbox
beara@battelle.org
-
Unclassified inbox
osborner@battelle.org
-
Unclassified inbox
stoutd@battelle.org
-
Unclassified inbox
avedon@battelle.org
-
Unclassified inbox
daxone@battelle.org
Seagen
Seagen is a clinical-stage biotechnology company dShow more...edicated to improving patient outcomes with advanced antibody-drug conjugate technology.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 12, 2024
Founded Date: 1998
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:SGEN
Operating Status: Active
23 Emails
0 Phones
Main email format: ssmith@seagen.com (37.5%)
-
Guy Padbury
Senior Vice President, Translational Sciences
g******y@seagen.com
-
Bryce Mansfield
Executive Director, R&D Quality
b********d@seagen.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k*****i@seagen.com
-
Davina Sparks Henderson
Sr Manager. Field Reimbursement
d********n@seagen.com
-
Virginie Oble Bouvet
v***e@seagen.com
-
Peter Senter
VP, Chemistry,VP, Distinguished Research Fellow
p***r@seagen.com
-
Marcel Koopman
International Product Manager Oncology
m******n@seagen.com
-
Jayeshkumar Soneji
j*****i@seagen.com
-
Scott Orchard
Senior Vice President and Associate General Counsel, Head of Transactional Law
s***********d@seagen.com
-
Swapnil Bhargava
Director, BioProcess Development
s*****l@seagen.com
-
Wendel Doubleday
Sr. Director, Chemical Development
w********y@seagen.com
-
Mark Cooley
Executive Director, IT Strategy and Operations
m**k@seagen.com
-
Monique M. Greer
Vice President, Corporate Communications
m*******r@seagen.com
-
Michael Gerstle
Director
m*****l@seagen.com
-
Clay Siegall
Founder
c**********l@seagen.com
-
Qi Jiang
Senior Vice President, Head of Biometrics
qi@seagen.com
-
Peggy Pinkston
Senior Vice President, Investor Relations
p************n@seagen.com
-
Stephan Thebault
Senior Vice President, Global Head of Quality
s**************t@seagen.com
-
General Inquiries
contact@seagen.com
-
Unclassified inbox
pcarter@seagen.com
-
Unclassified inbox
serviceclients@seagen.com
-
Unclassified inbox
ktreutlein@seagen.com
-
Unclassified inbox
pwalters@seagen.com
Eli Lilly
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Jul 8, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
23 Emails
0 Phones
Main email format: sarah.smith@lilly.com (66.7%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Sean Glennon
Director, International Business Unit Procurement at Eli Lilly and Company
g**********n@lilly.com
-
Ricardo Samms
Senior Research Scientist
s***********o@lilly.com
-
Paolo Romiti
Site Services Sr. Manager
r**********o@lilly.com
-
Cormac Gorman
Medical Sales Representative
g***********c@lilly.com
-
Maurizio Guidi
sr director Medical Affairs Capabilities and Opearation for ACE ( Australia, Canada, Europe)
g************o@lilly.com
-
Ann Connery
Vice President Quality - Drug Product Operations America/ Asia
c*********n@lilly.com
-
Devrim Dirik
Marketing Director
d**********m@lilly.com
-
Zhanglin Cui
Research Advisor
c**********n@lilly.com
-
Edgardo Hernandez
Sr. Vice President, Drug Product Manufacturing
h***************o@lilly.com
-
Tyron Johnson
Clinical Development Consultant
j***********n@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
b********e@lilly.com
-
Nmohamed Elsayed
n**************d@lilly.com
-
General Inquiries
kuga_atsushi@lilly.com
-
Unclassified inbox
hernandez_jorge_david@lilly.com
-
Unclassified inbox
rodriguez_mauricio_a@lilly.com
-
Unclassified inbox
coskun_tamer@lilly.com
-
Unclassified inbox
nmohamed.elsayed@lilly.com
Lonza
Lonza Group supplies products and services to pharShow more...maceutical and agrochemical industries.
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 1897
Number of Exits: 1
Company Type: For Profit
Stock Symbol: SWX:LONN
Operating Status: Active
22 Emails
0 Phones
Main email format: sarah.smith@lonza.com (100.0%)
-
Alice Harrison
Global Technical Director
a************n@lonza.com
-
Wolfgang D)
global Project Manager (Master Black Belt)
w***********k@lonza.com
-
Matthew Hall
Western Regional Sales Manager
m**********l@lonza.com
-
Donald Sohn, CFA
d*********n@lonza.com
-
Paul Tastenhoye
Program Management Leader Peptides/Braine
p*************e@lonza.com
-
Peter Aken
Global Head of Antifouling Paints and Aquaculture
p***********n@lonza.com
-
Klea Lenja
k********a@lonza.com
-
Peter Groenewege
Director Innovation Strategy & PMO (Capsules & Health ingredients)
p**************e@lonza.com
-
Eric Blomgren
Associate Director, Business Development
e***********n@lonza.com
-
Cameron Kadleck
Scientist
c*************k@lonza.com
-
Chris Maskell
Head Of Program Management
c***********l@lonza.com
-
Thomas Stuenkel
t*************l@lonza.com
-
Elissa Goldstein
e**************n@lonza.com
-
Wolfgang Zimmerer
z***************g@lonza.com
-
Leslie Turville
l*************e@lonza.com
-
Guangzhou Biologics
g*****************s@lonza.com
-
Bioscience China
b**************a@lonza.com
-
General Inquiries
info@lonza.com
-
Admin Team
admin@lonza.com
-
General Inquiries
contact@lonza.com
-
Unclassified inbox
chentwok.lim@lonza.com
-
Unclassified inbox
guixian.hu@lonza.com
Eli Lilly
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 6, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@lilly.com (50.0%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Sean Glennon
Director, International Business Unit Procurement at Eli Lilly and Company
g**********n@lilly.com
-
Ricardo Samms
Senior Research Scientist
s***********o@lilly.com
-
Paolo Romiti
Site Services Sr. Manager
r**********o@lilly.com
-
Cormac Gorman
Medical Sales Representative
g***********c@lilly.com
-
Maurizio Guidi
sr director Medical Affairs Capabilities and Opearation for ACE ( Australia, Canada, Europe)
g************o@lilly.com
-
Ann Connery
Vice President Quality - Drug Product Operations America/ Asia
c*********n@lilly.com
-
Devrim Dirik
Marketing Director
d**********m@lilly.com
-
Zhanglin Cui
Research Advisor
c**********n@lilly.com
-
Edgardo Hernandez
Sr. Vice President, Drug Product Manufacturing
h***************o@lilly.com
-
Tyron Johnson
Clinical Development Consultant
j***********n@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
bull_halle@lilly.com
-
General Inquiries
info@lilly.com
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company tShow more...hat develops generic and innovative medicines.
Specialized In: Pharmaceuticals, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Feb 12, 2024
Founded Date: 1901
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NYSE:TEVA
Operating Status: Active
21 Emails
0 Phones
Main email format: sarah.smith@tevapharm.com (61.5%)
-
Rob Koremans
President and CEO, Global Specialty Medicines
r*********s@tevapharm.com
-
Kathleen Veit
Vice President, Global Compliance & Ethics Operations & Investigations
k***********t@tevapharm.com
-
Aneta Filik
HR Director
a*********k@tevapharm.com
-
Kim Peetz
CFO Scandinavia
k*******z@tevapharm.com
-
Jacob Killian
Microbiologist III (Quality Control Analyst II)
j***********n@tevapharm.com
-
Sarah Cross
Senior Sales Specialist
s*********s@tevapharm.com
-
Danny Mcbryan
Senior Vice President, Head of Global Medical Affairs And Pharmacovigilance
d***********n@tevapharm.com
-
Melanie Nano Entena
Director, New Product Strategy - Respiratory
m************a@tevapharm.com
-
Zeno Ordan
Associate Director Total Rewards, Southern Europe
z********n@tevapharm.com
-
Anthony Dombrowski Cmr
Neurology Account Specialist
a*********r@tevapharm.com
-
Joost Cohen Tervaert
Advisory Board Member at Sanara Ventures
j************t@tevapharm.com
-
Brandon Goodman
Associate Director, Commercial Training at Blueprint Medicines
b*****n@tevapharm.com
-
Jim Stice
Professor
j*m@tevapharm.com
-
Tim Buchanan
Sales Director
t*m@tevapharm.com
-
Alicia Roeschke
Customer Enablement Manager at Grainger
a****a@tevapharm.com
-
Suman Bhattacharya
s****************a@tevapharm.com
-
Unclassified inbox
jobs.europe@tevaeu.com
-
Unclassified inbox
phil.wood@tevapharm.com
-
Unclassified inbox
randi.lewandowski@tevapharm.com
-
Unclassified inbox
gpgovernanceriskmanagement@tevapharm.com
-
Unclassified inbox
tevasuppliercodeofconduct@tevapharm.com
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discoveryShow more... and development of small molecule drugs for the treatment of serious diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 1, 2024
Founded Date: 1989
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:VRTX
Operating Status: Active
22 Emails
0 Phones
Main email format: sarah_smith@vrtx.com (64.3%)
-
Thomas Carney
Manager (GMP facility focus), Project Management Office, Global Capital Project Management
t***********y@vrtx.com
-
Gillian
Vice President, Strategic Operations, Regulatory Affairs and Quality
g@vrtx.com
-
Reshma Kewalramani
CEO and President
r****************i@vrtx.com
-
Javier Coindreau
VP Global Strategy Lead - Medical Affairs
j**************u@vrtx.com
-
Uma Raut
Director Global Regulatory Affairs, Cell and Gene Therapy
u******t@vrtx.com
-
Michele Bellandi
Vice President International Commercial
m**************i@vrtx.com
-
Elena Minichiello
Associate Director, Market Access Strategy and Planning
e***************o@vrtx.com
-
Rabah Chibane
Operations Supervisor
r***********e@vrtx.com
-
Robin Bean
Site Activation Manager
r********n@vrtx.com
-
Joshua Chen
VP Biostatistics
j*s@vrtx.com
-
Mark Yu
Senior Research Associate
m*****u@vrtx.com
-
Isaac Vasanthkumar
i****************r@vrtx.com
-
Guoxiang Ruan
g***********n@vrtx.com
-
Phillip Snyder
p************r@vrtx.com
-
Mac Johnson
Senior Director, Research, Vertex Pharmaceuticals
m*********n@vrtx.com
-
Morrey Atkinson
m*************n@vrtx.com
-
General Inquiries
mediainfo@vrtx.com
-
Unclassified inbox
cherif_benattia@vrtx.com
-
Unclassified inbox
chambers@vrtx.com
-
Unclassified inbox
gert_devoer@vrtx.com
-
Unclassified inbox
hanyu_zhu@vrtx.com
-
Unclassified inbox
panggao_duan@vrtx.com
Regeneron
Regeneron Pharmaceuticals specializes in the discoShow more...very, development, and commercialization of innovative medicines.
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Sep 6, 2024
Venture Stage: Early Stage Venture
Founded Date: 1988
Number of Exits: obfuscatedobfuscated
Company Type: For Profit
Stock Symbol: NASDAQ:REGN
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@regeneron.com (100.0%)
-
Boris Gorovits
b************s@regeneron.com
-
Jacky Space
j**************e@regeneron.com
-
Petra Rietschel
Senior Director Clinical Development ImmunoOncology
p*************l@regeneron.com
-
Catherine Armstrong Bccl
c************l@regeneron.com
-
Mena Soliman
m**********n@regeneron.com
-
Heather Hammond
h*************d@regeneron.com
-
Sarah Ghosh
s*********h@regeneron.com
-
Sofia Caruso
s**********o@regeneron.com
-
Jimmy Sanders
j***********s@regeneron.com
-
Lisa Flanagan
Director, Patent Attorney- Therapeutics IP
l***********n@regeneron.com
-
Madison Lee
m*********e@regeneron.com
-
Joseph Brown2
j***********2@regeneron.com
-
Chenguang Wang
c************g@regeneron.com
-
Rena Goins
r********s@regeneron.com
-
Unclassified inbox
thomas.daly@regeneron.com
-
Unclassified inbox
david.glass@regeneron.com
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical compShow more...any focusing on developing and commercializing innovative cancer therapeutics.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 7, 2022
Founded Date: 2011
Company Type: For Profit
Stock Symbol: NASDAQ:FLGT
Operating Status: Active
22 Emails
1 Phones
Main email format: ssmith@fulgentgenetics.com (69.2%)
-
James Liu
Director of System Architecture,Enterprise Systems Architect
j**u@fulgentgenetics.com
-
Lawrence Weiss
l****s@fulgentgenetics.com
-
Ming Hsieh
m*******h@fulgentgenetics.com
-
Alex Witterschein
a**************n@fulgentgenetics.com
-
Erin Heaney
e*****y@fulgentgenetics.com
-
Eric Chen
e******n@fulgentgenetics.com
-
Rod Gervacio
CLS Lead
r*******o@fulgentgenetics.com
-
Spencer Young
Solutions/Software Analyst/Scientist/Engineer
s****g@fulgentgenetics.com
-
Benjamin Ramos
Talent Acquisition Specialist
b****s@fulgentgenetics.com
-
Doreen Ng
VP, Operations & Compliance | General Manager (Houston)
d******g@fulgentgenetics.com
-
Natalie Prescott
General Counsel & Chief Privacy Officer
n*******t@fulgentgenetics.com
-
Hanlin Gao
Lab Director and Chief Scientific Officer
h**o@fulgentgenetics.com
-
Paul Kim
Chief Financial Officer
p**m@fulgentgenetics.com
-
General Inquiries
info@fulgentgenetics.com
-
Customer Service
lacsupport@fulgentgenetics.com
-
Unclassified inbox
insurance@fulgentgenetics.com
-
General Inquiries
info@fulgent-therapeutics.com
-
Unclassified inbox
preverification@fulgentgenetics.com
-
Unclassified inbox
applyjob@fulgentgenetics.com
-
Unclassified inbox
ajariwala@fulgentgenetics.com
-
Unclassified inbox
rblake@fulgentgenetics.com
-
Customer Service
labservices@fulgentgenetics.com
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a specialty pharmaceuticalShow more... company that identifies, develops and commercializes innovative treatments.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 28, 2024
Founded Date: 2003
Company Type: For Profit
Stock Symbol: NASDAQ:JAZZ
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@jazzpharma.com (100.0%)
-
Bruce Cozadd
Chief Executive Officer
b**********d@jazzpharma.com
-
Charlotte Nortvedt
c****************t@jazzpharma.com
-
Sam Hills
Global Workplace / Facilities Manager
s*******s@jazzpharma.com
-
Remy Sakkers
r**********s@jazzpharma.com
-
Lynette Thomas
l************s@jazzpharma.com
-
James Cekola
Corporate Counsel, Intellectual Property Litigation
j**********a@jazzpharma.com
-
Valmira Hoxhaj
v************j@jazzpharma.com
-
Todd Johnson
t**********n@jazzpharma.com
-
Robert Fell
r*********l@jazzpharma.com
-
Temire Bobegbe
t************e@jazzpharma.com
-
Kevin Jaron
k*********n@jazzpharma.com
-
Erin Chenault
e***********t@jazzpharma.com
-
Maria Heinrich
m************h@jazzpharma.com
-
General Inquiries
investorinfo@jazzpharma.com
-
General Inquiries
contact@jazzpharma.com
-
Unclassified inbox
jeffrey.tobias@jazzpharma.com
Horizon Pharma
Horizon Therapeutics focuses on the development ofShow more... prescription drugs for mild to moderate pain relief and arthritis.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active
17 Emails
1 Phones
Main email format: ssmith@horizontherapeutics.com (54.5%)
-
Shvetali Thatte
s*************e@horizontherapeutics.com.If
2**********0
-
Tina Ventura
t**********a@horizontherapeutics.com
-
Lou Scerbo
l*****o@horizontherapeutics.com
-
Maria Tello
m****o@horizontherapeutics.com
-
Randall Schenck
r*************k@horizontherapeutics.com
-
Paul Vanek
p********k@horizontherapeutics.com
-
Anne O'Donnell
a*******l@horizontherapeutics.com
-
Todd Smith
t****h@horizontherapeutics.com
-
James Inglis
j*****s@horizontherapeutics.com
-
John Croatt
Regional Account Director
j*********t@horizontherapeutics.com
-
Liz Gutierrez
l********z@horizontherapeutics.com
-
Susanna Frydryk
s******k@horizontherapeutics.com
-
Customer Service
customerservice@horizontherapeutics.com
-
Unclassified inbox
jwhalen@horizonpharma.com
-
Unclassified inbox
dbriley@horizontherapeutics.com
-
Unclassified inbox
nmosdspecialistfinder@horizontherapeutics.com
-
Unclassified inbox
amilstead@horizontherapeutics.com
CVSPharmacy
CVSPharmacy is a retail pharmacy that offers prescShow more...ription drugs, over-the-counter drugs, beauty products, and cosmetics.
Specialized In: Consumer Goods & FMCG, Healthcare & Medical, Pharmaceuticals, E-commerce & Retail
Business Type: Private
Employees: 10001+
Rounds: Debt Financing
Last Investment Activity: Mar 12, 2024
Founded Date: 1963
Company Type: For Profit
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@cvs.com (81.8%)
-
Brittany Starcher
b*******r@cvs.com
-
Kelly Panuska
k******a@cvs.com
-
Edith M Pagan
e*****n@cvs.com
-
Dan Mccoy
d****y@cvs.com
-
Christine Molina
c*****a@cvs.com
-
Mai Vang
m***g@cvs.com
-
Doni Bobes
d****s@cvs.com
-
Sherri Potenzone
s********e@cvs.com
-
Omar Monarrez
o*******z@cvs.com
-
Carolyn Craft
c***t@cvs.com
-
Nagma Gargi
ngargi@cvs.com
-
General Inquiries
info@cvs.com
Cipla
Cipla is a drug manufacturing company that focusesShow more... on a variety of pharmaceutical products.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Jul 28, 2024
Founded Date: 1935
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NSE:CIPLA
Operating Status: Active
19 Emails
0 Phones
Main email format: sarah.smith@cipla.com (90.9%)
-
Yusuf Hamied
Chairman of the Board
y**********d@cipla.com
-
Narendra Choudhari
Director & Sr Marketing Head Cipla Ltd.
n****************i@cipla.com
-
Mangesh Vaze
Sr Director
m**********e@cipla.com
-
Priya Hargunani
Deputy Manager Medical Services (Oncology)
p*************i@cipla.com
-
Prathamesh Govekar
Director
p****************r@cipla.com
-
Lakshya Patil
Production Officer
l***********l@cipla.com
-
Devaughn Stephens
Head of Human Resources @ InvaGen Pharmaceuticals, Inc.
d***************s@cipla.com
-
Rathindra Das
Management Staff-Finance (Corporate Regulatory)
r***********s@cipla.com
-
Samina Vaziralli
Global Head - Strategy & New Ventures
s****a@cipla.com
-
Satyen Manikani
s*************i@cipla.com
-
Aakanksha Yadav
a*************v@cipla.com
-
General Inquiries
contactus@cipla.com
-
Unclassified inbox
Cipla.cs@cipla.com
-
General Inquiries
Contact@cipla.com
-
Unclassified inbox
drugsafety@cipla.com
-
Unclassified inbox
dlhreg@cipla.com
-
Unclassified inbox
vijay.yadav@cipla.com
-
Unclassified inbox
ibhrhub@cipla.com
-
Unclassified inbox
athrhubwest@cipla.com
KBI Biopharma
KBI Biopharma, Inc. (KBI) is a leading developmentShow more... and contract manufacturing organization serving the biopharmaceutical industry. We help
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Apr 15, 2024
Founded Date: 1996
Number of Exits: 3
Company Type: For Profit
Operating Status: Active
18 Emails
0 Phones
Main email format: ssmith@kbibiopharma.com (100.0%)
-
Chad Cleveland
Director - Data Integrity | Global Quality & Compliance
c********d@kbibiopharma.com
-
Nicolas Fouque
Director of Manufacturing Science and Technologies - Geneva
n*****e@kbibiopharma.com
-
Allison Fallon
Talent Acquisition Specialist III
a*****n@kbibiopharma.com
-
Davinder Singh
Vice President Finance
d****h@kbibiopharma.com
-
Jeanie Lipscombe
Recruiting Specialist
j*****s@kbibiopharma.com
-
Robin Elleston
Director Of Quality Assurance
r*******n@kbibiopharma.com
-
Thomas Bellocci
Supply Chain Director
t*******i@kbibiopharma.com
-
Simon Bickley
Director Global Procurement
s******y@kbibiopharma.com
-
Chandra Kelley
Vice President, Business Development
c*****y@kbibiopharma.com
-
Chioma Otti
Microbiology Specialist
c***i@kbibiopharma.com
-
Marykay Marchigiani
Chief Financial Officer
m**********i@kbibiopharma.com
-
Unclassified inbox
swakefield@kbibiopharma.com
-
General Inquiries
contact@kbibiopharma.com
-
Unclassified inbox
khurshid.iqbal@kbibiopharma.com
-
Unclassified inbox
kiqbal@kbibiopharma.com
-
Unclassified inbox
jchambless@kbibiopharma.com
-
Unclassified inbox
jrocher@kbibiopharma.com
-
Unclassified inbox
inc.bbentley@kbibiopharma.com
Albany Molecular Research
“Albany Molecular Research Inc. provides scientifiShow more...c services, products and technologies that improve quality of life while delivering
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Delisted
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 20, 2021
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:AMRI
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@amriglobal.com (100.0%)
-
Andrew Boze
Research Scientist I
a*********e@amriglobal.com
-
Steven Pawlows
Senior Manager
s************s@amriglobal.com
-
Susan Billings
Vice President & Global Head of Business Development
s************s@amriglobal.com
-
Griffin White
g***********e@amriglobal.com
-
Ikia Pwalther
Senior Director Business Development
i***********r@amriglobal.com
-
Tim Tuegel
t********l@amriglobal.com
-
Michael Haswell
m*************l@amriglobal.com
-
Shane Brown
s*********n@amriglobal.com
-
Debasis Patra
d***********a@amriglobal.com
-
Anandasekar Rangsamy
a******************y@amriglobal.com
-
Cheryl Movsesian
c**************n@amriglobal.com
-
General Inquiries
InvestorInfo@amriglobal.com
-
Unclassified inbox
patty.eisenhaur@amriglobal.com
-
Unclassified inbox
seena.sankar@amriglobal.com
-
Unclassified inbox
matthew.isherwood@amriglobal.com
-
Unclassified inbox
pamela.goh@amriglobal.com
An executive agency of the Department of Health, eShow more...xists to enhance and improve the health of millions of people every day.
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 29, 2023
Founded Date: Jan 1, 2003
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Investor Type: Government Office
11 Emails
0 Phones
Main email format: sarah.smith@gov.uk (100.0%)
-
Sadiq Khan
s********n@london.gov.uk
-
Antony Phillipson
a***************n@fco.gov.uk
-
Gerwyn Evans
g**********s@wales.gsi.gov.uk
-
Max Caller
m********r@birmingham.gov.uk
-
Robin Porter
r**********r@luton.gov.uk
-
Jason Leitch
j**********h@scotland.gsi.gov.uk
-
Antonia Romeo
Permanent Secretary
a***********o@cabinetoffice.gov.uk
-
John Mills
j********s@fife.gov.uk
-
Antony Phillipson
a***************n@www.gov.uk
-
Antonia Romeo
Permanent Secretary
a***********o@justice.gsi.gov.uk
-
Archie Laing
archie.laing@gov.uk
-
General Inquiries
info@gov.uk
1mg
1mg is an online pharmacy network platform and genShow more...eric medicine engine.
Specialized In: E-commerce & Retail, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 51-100
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 8, 2022
Founded Date: Feb 3, 2015
Company Type: For Profit
Operating Status: Active
18 Emails
1 Phones
Main email format: sarah.smith@1mg.com (40.0%)
-
Prashant Tandon
CEO & Co-Founder
p******t@1mg.com
-
Gaurav Agarwal
Co-Founder & CTO
g*****a@1mg.com
*********4
-
Ravish Aanand
r***********d@1mg.com
-
Mike McGarr
Senior Engineering Leader, Desktop Foundations at Slack
mm@1mg.com
-
Tanmay Saksena
Chief Operating Officer
t****y@1mg.com
-
Arpit Sarin
Head- Marketplace Operations,Head of Business Insights- Retail
a*********n@1mg.com
-
Nitin Bhasin
n**********n@1mg.com
-
Hemant Parasar
h************r@1mg.com
-
Avisek Bhattacharya
Senior UX Designer
a****k@1mg.com
-
Akash Deep Singhal
Founder
a*************l@1mg.com
-
General Inquiries
info@1mg.com
-
General Inquiries
hello@1mg.com
-
Customer Service
support@1mg.com
-
Sales Department
sales@1mg.com
-
Legal Department
legal@1mg.com
-
Unclassified inbox
care@1mg.com
-
Unclassified inbox
only@1mg.com
-
Unclassified inbox
plus@1mg.com
Sartorius
Sartorius helps its customers to develop and manufShow more...acture biotech medicines reliably, quickly, and economically.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 18, 2024
Founded Date: 1870
Company Type: For Profit
Stock Symbol: ETR:SRT3
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@sartorius.com (100.0%)
-
Joachim Kreuzburg
Chairman of the Executive Board and CEO
j***************g@sartorius.com
-
Mareva Gueneron
Head Of Project Management Office (PMO)
m*************n@sartorius.com
-
Floris Smet
Manager - Process Development Consultants
f***********t@sartorius.com
-
Jeannine Hillmer
Field Account Manager
j**************r@sartorius.com
-
Sven Wagner
Head of Business Development
s*********r@sartorius.com
-
Vincent Galione
Digital Account Manager - Southeast
v*************e@sartorius.com
-
Dominik Kopp
Manager IT Service Framework
d**********p@sartorius.com
-
Jeanette Minshall
j***************l@sartorius.com
-
Jens Matuszczyk
j*************k@sartorius.com
-
Katrin Toeppner
k*************r@sartorius.com
-
General Inquiries
info@sartorius.com
-
Admin Team
admin@sartorius.com
-
General Inquiries
info@sartorius-stedim.com
-
Unclassified inbox
info.austria@sartorius.com
-
Unclassified inbox
guido.schmidbauer@sartorius.com
Sorrento Therapeutics
Sorrento Therapeutics is focused on the developmenShow more...t of proprietary drug therapeutics for addressing unmet medical needs.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2024
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SRNE
Operating Status: Active
17 Emails
0 Phones
Main email format: ssmith@sorrentotherapeutics.com (100.0%)
-
Jaisim Shah
President & Chief Executive Officer
j***h@sorrentotherapeutics.com
-
Yan Li
Senior Scientist, Antibody Technology Development
y*i@sorrentotherapeutics.com
-
Dean Ferrigno
Vice President Of Finance
d*******o@sorrentotherapeutics.com
-
Vanessa Mendez
Quality
v*****z@sorrentotherapeutics.com
-
Ryan Tang
It Director
r***g@sorrentotherapeutics.com
-
Dindo Sy Chu
Vice President Finance
d**u@sorrentotherapeutics.com
-
Hua Huang
Director
h****g@sorrentotherapeutics.com
-
Mark Brunswick
SVP Head of Regulatory Affairs and Quality
m********k@sorrentotherapeutics.com
-
Silvia Chang
Head of Small Molecule Program Management/Executive Director Program Management
s****g@sorrentotherapeutics.com
-
Meredith Childers
Senior Writer
m*******s@sorrentotherapeutics.com
-
General Inquiries
info@sorrentotherapeutics.com
-
Admin Team
admin@sorrentotherapeutics.com
-
Management Department
manager@sorrentotherapeutics.com
-
Legal Department
legal@sorrentotherapeutics.com
-
Unclassified inbox
investoren@sorrentotherapeutics.com
-
Unclassified inbox
doanh@sorrentotherapeutics.com
-
Unclassified inbox
investisseurs@sorrentotherapeutics.com
Prime Therapeutics
Prime Therapeutics is an independent pharmacy beneShow more...fit manager that primarily serves Blue Cross Blue Shield plans
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Last Investment Activity: Jun 10, 2024
Founded Date: 1990
Company Type: For Profit
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@primetherapeutics.com (77.8%)
-
Mostafa Kamal
Chief Executive Officer and President
m***********l@primetherapeutics.com
-
Jing Kang
Specialty Clinical Program Director
j***g@primetherapeutics.com
-
Melissa Hogstad
Director Pharmacy Trade Relations
m******d@primetherapeutics.com
-
Shannon Brogden
Pharmacy Technician
s*************n@primetherapeutics.com
-
Caitlin Sandin
Sr. Clinical Review Technician
c************n@primetherapeutics.com
-
John Klimek
IT Budget and Resource Manager
j*********k@primetherapeutics.com
-
Amanda Leemhuis
Technician
a*************s@primetherapeutics.com
-
Laura Nadeau
Enterprise Portfolio Management Principal
l**********u@primetherapeutics.com
-
Chris Janssens
Senior Director, Trade Client Relations
c************s@primetherapeutics.com
-
Cameron M Kracke
c*****e@primetherapeutics.com
-
Unclassified inbox
RxNetworksDept@primetherapeutics.com
Allergan
Allergan is a global pharmaceutical company.
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals, Universities & Colleges
Acquired by: AbbVie
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 13, 2024
Founded Date: 1948
Company Type: For Profit
Stock Symbol: NYSE:AGN
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@allergan.com (100.0%)
-
Natalie Anderten
Director, Clinical Development Operations
c************e@allergan.com
-
Lou Foytik
Associate Director, Contract Account Management
f********u@allergan.com
-
Vicky Yuan
Pr. Statistical SAS Programmer
y********y@allergan.com
-
Delaney Ahern
Brand Marketing, BOTOX® Cosmetic
a***********y@allergan.com
-
Viresh Thakerar
International External Innovation Lead
t*************h@allergan.com
-
Jamie Weidle
Senior Business Development Manager
w**********e@allergan.com
-
George Saltzberg
s**************e@allergan.com
-
Sharon DeFeo
d**********n@allergan.com
-
Quality Switzerland
q*****************d@allergan.com
-
Marcy Schwoegler
m**************r@allergan.com
-
Investor Relations
edith.auclair@allergan.com
-
Unclassified inbox
mora_yolanda@allergan.com
-
Unclassified inbox
me-serv_clientes@allergan.com
Albemarle
Albemarle is a specialty chemical company focused Show more...on lithium, bromine, and refining catalysts.
Specialized In: Manufacturing & Industrial, Construction Companies, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 1994
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NYSE:ALB
Operating Status: Active
12 Emails
0 Phones
Main email format: sarah.smith@albemarle.com (100.0%)
-
Tatiana Lo
LAUNCH Rotational Program Associate Engineering
t********o@albemarle.com
-
Samantha Stutz
Process Engineer
s************z@albemarle.com
-
Tamaria Lynch
Vice President Finance
t***********h@albemarle.com
-
Jesse Counihan
North America Region Procurement Manager
j************n@albemarle.com
-
Eric Brooks
Key Account Manager
e*********s@albemarle.com
-
Patrick Thompson
Chief Information & Digital Transformation Officer
p**************n@albemarle.com
-
Chris Faria
c*********a@albemarle.com
-
Apurba Sakti
Data Science Advisor
a**********i@albemarle.com
-
Jeroen Plas
j*********s@albemarle.com
-
Sales Department
albsales@albemarle.com
-
Unclassified inbox
janpieter.fortuin@albemarle.com
-
Unclassified inbox
john.kuhn@albemarle.com
Ferring
Ferring is a biopharmaceutical company that develoShow more...ps reproductive medicine for healthacare sectors.
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Debt Financing
Last Investment Activity: Jan 16, 2024
Founded Date: 1950
Company Type: For Profit
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@ferring.com (100.0%)
-
Casper Johansen
Director Business Development, Search & Evaluation
c*************n@ferring.com
-
Emilia Brusco
HR Director, South America
e***********o@ferring.com
-
Elda Dinaj
Global Strategic Brand Leader, Gastroenterology & Endocrinology
e********j@ferring.com
-
Camilla Munksgaard
Associate Director, HR
c****************d@ferring.com
-
Brent Ragans
President, Ferring Pharmaceuticals U.S.
b**********s@ferring.com
-
Phil Hanfling
Manager, Site Contracts
p***********g@ferring.com
-
Anie Azroyan, PhD, MBA
a**********n@ferring.com
-
Safety Indiamailbox
s*****************x@ferring.com
-
Jobs India
j********a@ferring.com
-
General Inquiries
info@ferring.com
-
Admin Team
admin@ferring.com
-
Investor Relations
investor@ferring.com
-
General Inquiries
contact@ferring.com
-
Sales Department
sales@ferring.com
-
Unclassified inbox
ecs@ferring.com
-
Unclassified inbox
nicholas.borgia@ferring.com
-
Unclassified inbox
l@ferring.com
Ginkgo Bioworks
Ginkgo Bioworks is a developer of biological enginShow more...eering products and custom microbes across multiple markets.
Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial
Business Type: Public
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 27, 2024
Founded Date: 2008
Number of Exits: 1
Company Type: For Profit
Stock Symbol: BMV:DNA
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah@ginkgobioworks.com (62.5%)
-
Christina Agapakis
Creative Director
c*******a@ginkgobioworks.com
-
Ken Situ
It Consultant
k******u@ginkgobioworks.com
-
Zachary King
Director Of Marketing Operations
z**********g@ginkgobioworks.com
-
Jhonny Martinez
Facilities Technician
j*************z@ginkgobioworks.com
-
Sean Leblanc
Senior Director of Foundry Operations
s**n@ginkgobioworks.com
-
Yaoyu Yang
Principal Software Engineer
y***u@ginkgobioworks.com
-
Tomek Brzezinski
Automation Engineer
t***k@ginkgobioworks.com
-
Soon Gang Choi
Senior Test Engineer
s**n@ginkgobioworks.com
-
Ian Meyer
Associate Director, Strategic Finance
i*n@ginkgobioworks.com
-
General Inquiries
info@ginkgobioworks.com
-
Investor Relations
20investors@ginkgobioworks.com
-
General Press Inquiries
20press@ginkgobioworks.com
-
Unclassified inbox
jason@ginkgobioworks.com
-
Unclassified inbox
curt@ginkgobioworks.com
-
Unclassified inbox
aailloni@ginkgobioworks.com
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
15 Emails
0 Phones
Main email format: ssmith@loxooncology.com (87.5%)
-
Lee S Scheible
Director, Early Phase Oncology, Loxo Oncology at Lilly
l*******e@loxooncology.com
-
Jinmi Heo
Director
j**o@loxooncology.com
-
Tamas Benkovics
Director
t********s@loxooncology.com
-
Alba Luengo
Principal Scientist
a*****o@loxooncology.com
-
Bojana Jovanovic
Senior Scientific Lead, Clinical Biomarker Development
b********c@loxooncology.com
-
Tracey Marrone
Talent Acquisition Manager
t******e@loxooncology.com
-
Nathan Wright
Research Fellow
n*****t@loxooncology.com
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com
-
Unclassified inbox
careers@loxooncology.com
-
Unclassified inbox
jake@loxooncology.com
-
Unclassified inbox
bschmitz@loxooncology.com
-
Unclassified inbox
cbethune@loxooncology.com
Genzyme
Genzyme Corporation (Genzyme) is a biotechnology cShow more...ompany. The Company's product and service portfolio is focused on rare genetic disease
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Private
Employees: 10001+
Last Investment Activity: Jul 30, 2024
Founded Date: 1981
Number of Exits: 3
Company Type: For Profit
Operating Status: Closed
11 Emails
0 Phones
Main email format: sarah.smith@genzyme.com (100.0%)
-
Helene Nagy
Label Development Manager, Clinical Supplies
h*********y@genzyme.com
-
Patti Nardi
Head of Global Product Supply Chain
p*********i@genzyme.com
-
Philippe Mazars
Quality Control Associate Director
p*************s@genzyme.com
-
Bryan Gillis
b**********s@genzyme.com
-
Eliana Clark
Chief Technical Officer
e**********k@genzyme.com
-
Morrill Reynolds
Principal Project Manager
m**************s@genzyme.com
-
Louise Harney
l***********y@genzyme.com
-
Richard Garman
r************n@genzyme.com
-
Mary Chabot
m*********t@genzyme.com
-
Unclassified inbox
carlos.figueroachamorro@genzyme.com
-
Unclassified inbox
nic.grund@genzyme.com
Horizon Discovery
Horizon is a gene editing company that designs & eShow more...ngineers genetically-modified cells, applying them to advance human health.
Specialized In: Pharmaceuticals, Biotechnology, Health Diagnostics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 10, 2022
Founded Date: Jun 2007
Company Type: For Profit
Stock Symbol: LSE:HZD
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@horizondiscovery.com (100.0%)
-
Kevin Koker
Customer Service Manager
k*********r@horizondiscovery.com
-
Jon Aviles
General Manager
j********s@horizondiscovery.com
-
Natalie Cowan
Business Development Manager
n***********n@horizondiscovery.com
-
Jon Nunez
Vice President , Finance
j*******z@horizondiscovery.com
-
Jeffrey Dale
Business Development Manager, Midwest (South), Products and Services (including In Vivo)
j**********e@horizondiscovery.com
-
Abhay Joshi
Business Development Manager
a*********i@horizondiscovery.com
-
Hadas Raveh-Amit
Senior Scientist
h*************t@horizondiscovery.com
-
Andrea Frapporti
a**************i@horizondiscovery.com
-
U003eandrea Frapporti
u*******************i@horizondiscovery.com
-
General Inquiries
info@horizondiscovery.com
-
Sales Department
sales@horizondiscovery.com
-
Legal Department
legal@horizondiscovery.com
-
Unclassified inbox
j.moore@horizondiscovery.com
-
Unclassified inbox
darrin.disley@horizondiscovery.com
-
Unclassified inbox
noreply@horizondiscovery.com
Indivior
Indivior is a specialty pharmaceuticals business.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 21, 2024
Founded Date: 2014
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:INDV
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@indivior.com (100.0%)
-
Cathy Thomas
National Sales Manager
c**********s@indivior.com
-
Jennie Witherspoon
Sr. Clinical Specialist
j****************n@indivior.com
-
Diana Minervini
Channel/Trade Accounts
d*************i@indivior.com
-
Sincear Fountain
Regional Account Director
s**************n@indivior.com
-
Naomi Guinness
UK & Ireland Talent Acquisition Specialist (VIA Korn Ferry RPO)
n************s@indivior.com
-
Steve Johnson
Senior Area Sales Manager - Behavioral Health
s***********n@indivior.com
-
Rob Vinson
Specialty Sales Consultant|Injectables Buy and Bill|Product Launches
r********n@indivior.com
-
Fred Jumper
f*********r@indivior.com
-
Lynn Taylor
l*********r@indivior.com
-
Unclassified inbox
Tom.Corran@indivior.com
-
Unclassified inbox
patientsafetyfrance@indivior.com
-
Unclassified inbox
patientsafetyna@indivior.com
-
Unclassified inbox
trialdisclosure@indivior.com
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Oralcare Maroc
o************c@pierre-fabre.com
-
Services Canada
s*************a@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
-
Unclassified inbox
ultan.power@pierre-fabre.com
-
Unclassified inbox
marie.bernadette.assie@pierre-fabre.com
-
Unclassified inbox
oralcare.maroc@pierre-fabre.com
-
Unclassified inbox
services.canada@pierre-fabre.com
-
Unclassified inbox
oncology.nl@pierre-fabre.com
Owkin
Owkin is an AI precision medicine company with a vShow more...ision to find the right drug for every patient.
Specialized In: AI & Machine Learning, Pharmaceuticals, Healthcare SaaS, SaaS
Business Type: Private
Employees: 251-500
Rounds: Series B
Last Investment Activity: Mar 26, 2024
Founded Date: 2016
Company Type: For Profit
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@owkin.com (71.4%)
-
Thomas Clozel
Co-Founder & CEO
tc@owkin.com
-
Thomas Clozel
Co-Founder & CEO
t***********l@owkin.com
-
Gilles Wainrib
Founder
gw@owkin.com
-
Darius Meadon
Chief Marketing Officer
d***********n@owkin.com
-
Antonia Twiston-Davies
a************r@owkin.com
-
Nicolas Loiseau
n*************u@owkin.com
-
Anna Huyghues-Despointes
Head of Strategy
a**********************s@owkin.com
-
Jeremy Guillon
Machine Learning Engineer
j************n@owkin.com
-
General Inquiries
hello@owkin.com
-
Customer Service
support@owkin.com
-
General Inquiries
contact@owkin.com
-
Sales Department
sales@owkin.com
-
Legal Department
legal@owkin.com
-
Unclassified inbox
gilles.wainrib@owkin.com
-
Unclassified inbox
camille.marini@owkin.com
-
Unclassified inbox
u003ehiring@owkin.com
-
Unclassified inbox
dpo@owkin.com
Purdue Pharma
Purdue Pharma develops, manufactures, and markets Show more...medications and consumer health products.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Dec 4, 2023
Founded Date: 1892
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@purduepharma.com (62.5%)
-
Cherilyn Calia
Business Analyst
c************a@purduepharma.com
-
Bill Watson
w****n@purduepharma.com
-
Heather Jordan
Industry Account Executive at SAP
j****n@purduepharma.com
-
Stephen Rayda
Global Head of Infrastructure and Client Services at Purdue Pharma L.P.
s***********a@purduepharma.com
-
Donna Krizik
Experienced Marketing Director | SEO | B2B Marketer | Content Strategist
dk@purduepharma.com
-
Marc Kesselman
S.V.P. & General Counsel
m************n@purduepharma.com
-
Stuart Baker
s**********r@purduepharma.com
-
Stuartd Baker
s***********r@purduepharma.com
-
General Inquiries
purduemedInfo@pharma.com
-
Unclassified inbox
ann.kraft@purduepharma.com
-
Unclassified inbox
brianne.weingarten@purduepharma.com
inVentiv Health
inVentiv Health offers clinical and commercial proShow more...fessional services to help biopharmaceutical companies streamline their processes.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Private Equity
Last Investment Activity: Jan 11, 2018
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Operating Status: Closed
12 Emails
0 Phones
Main email format: sarah.smith@inventivhealth.com (100.0%)
-
Yuet Mei Han
IT Senior Analyst
y******n@inventivhealth.com
-
Jim Owers
Director, Digital Strategy and Head of Digital Production
j*******s@inventivhealth.com
-
Ann-Marie Terry
Clinical Research Associate II
a************y@inventivhealth.com
-
Latrell Rivers
l************s@inventivhealth.com
-
Vaibhav Divekar
Senior CDM
v*************r@inventivhealth.com
-
Martin Prosser
Senior Business Development Director
m************r@inventivhealth.com
-
Thomas Carlo Maria Topini
t***********i@inventivhealth.com
-
Yuliia Bahatska
y*************a@inventivhealth.com
-
Unclassified inbox
bruce.crawford@inventivhealth.com
-
Unclassified inbox
michael.estes@inventivhealth.com
-
Unclassified inbox
cannesdo@inventivhealth.com
-
Unclassified inbox
ncannesdo@inventivhealth.com
Piramal Enterprises
Piramal Group is a diversified conglomerate with oShow more...perational presence in pharma, financial services, information management and real estate.
Specialized In: Finance & Banking, Technology & Software, Pharmaceuticals, Real Estate Agencies & Brokers
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 13, 2024
Founded Date: Dec 2, 1992
Company Type: For Profit
Stock Symbol: NSE:PEL
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@piramal.com (100.0%)
-
Nandini Piramal
Executive Director
n*************l@piramal.com
-
Swati Piramal
Vice Chairperson
s***********l@piramal.com
-
Ajay Piramal
Chairman
a**********l@piramal.com
-
Harinder Sikka
Group Director
h************a@piramal.com
-
Unmesh
Vice President Human Resources
u********i@piramal.com
-
Vinay Bura
v********a@piramal.com
-
Sanjay Mishra
s***********a@piramal.com
-
Businessoperations Grangemouth
b****************************h@piramal.com
-
Unclassified inbox
customercare@piramal.com
-
Unclassified inbox
nodal.officer@piramal.com
-
Unclassified inbox
medical.information@piramal.com
-
Unclassified inbox
contact.us@piramal.com
-
Unclassified inbox
goldee.pardesi@piramal.com
-
General Inquiries
mangesh.joshi@piramal.com
-
Unclassified inbox
vinay.bura@piramal.com
-
Unclassified inbox
sanjay.mishra@piramal.com
-
Unclassified inbox
businessoperations.grangemouth@piramal.com
Canopy Growth
Canopy Growth is a cannabis consumer product compaShow more...ny that manufactures medical cannabis to improve lives.
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: 2014
Number of Exits: 3
Company Type: For Profit
Stock Symbol: TSX:WEED
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@canopygrowth.com (100.0%)
-
Bruce Linton
Founder
b**********n@canopygrowth.com
-
Rachit Gupta
Cloud Engineer - DBA Specialist
r**********a@canopygrowth.com
-
Ross Fenwick
Manager, Talent Acquisition
r**********k@canopygrowth.com
-
Scott W Huddle
s**********e@canopygrowth.com
-
Christelle Gedeon
Partner
c***************n@canopygrowth.com
-
Paul Steckler
p***********r@canopygrowth.com
-
Hans Vanhaeff
h***********f@canopygrowth.com
-
Foxhall Parker
f************r@canopygrowth.com
-
Unclassified inbox
invest@canopygrowth.com
Servier
Servier is an pharmaceutical company governed by aShow more... non-profit foundation.
Specialized In: Healthcare & Medical, Medical Devices, Pharmaceuticals
Acquired by: AIvarix
Business Type: Private
Employees: 10001+
Last Investment Activity: Aug 7, 2024
Founded Date: 1954
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@servier.com (100.0%)
-
Victoria Vandzhura
International Project Director
v****************a@servier.com
-
François Tharaux
Alliance Director Business Development & Licensing
f**************x@servier.com
-
Sanket Salvi
Sr. Human Resources Business Partner
s**********i@servier.com
-
Walid Kamoun
Vice President, Global Head of R&D Oncology
w**********n@servier.com
-
Thomas Reynaud
Data Tech Lead
t************d@servier.com
-
Natalia Jablonska
n***************a@servier.com
-
George Paraschiv
g**************v@servier.com
-
Roxana Stanescu
r*************u@servier.com
-
General Press Inquiries
presse@servier.com
-
Unclassified inbox
robert.djundjek@servier.com
-
Unclassified inbox
webmaster@servier.com
Cytokinetics
Cytokinetics is a biopharmaceutical company develoShow more...ping therapies for debilitating diseases.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Mar 15, 2024
Founded Date: 1998
Company Type: For Profit
Stock Symbol: NASDAQ:CYTK
Operating Status: Active
16 Emails
0 Phones
Main email format: ssmith@cytokinetics.com (100.0%)
-
Robert Blum
President & CEO
r***m@cytokinetics.com
-
Kymberly Hernandez
HR Director, Commercial and Medical Affairs
k********z@cytokinetics.com
-
Dean Reid
d***d@cytokinetics.com
-
Regina Sohn
Medical Director
r***n@cytokinetics.com
-
Tina Controy
t******y@cytokinetics.com
-
Ronald Vale
Co-Founder, Cytokinetics; Professor and Howard Hughes Investigator
r***e@cytokinetics.com
-
Eric Terhaerdt
Senior Vice President, Development Operations
e********t@cytokinetics.com
-
General Inquiries
info@cytokinetics.com
-
Investor Relations
investor@cytokinetics.com
-
Legal Department
legal@cytokinetics.com
-
Unclassified inbox
medicalaffairs@cytokinetics.com
-
Unclassified inbox
compliance@cytokinetics.com
-
Unclassified inbox
jtrautman@cytokinetics.com
-
Unclassified inbox
sbarbari@cytokinetics.com
-
Unclassified inbox
mpugsley@cytokinetics.com
-
Unclassified inbox
medicalinformation@cytokinetics.com
Mirati Therapeutics
Mirati Therapeutics is a Biotechnology company locShow more...ated in 9363 Towne Centre Dr, San Diego, CA, United States.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Jan 24, 2024
Founded Date: Dec 13, 1995
Company Type: For Profit
Stock Symbol: NASDAQ:MRTX
Operating Status: Active
13 Emails
0 Phones
Main email format: ssmith@mirati.com (60.0%)
-
James Christensen
Chief Scientific Officer
c**********j@mirati.com
-
Jing He
Associate Director Biostatistics
j*e@mirati.com
-
Maggie Ryan Laughlin
Human Resources Director, Human Resources Business Partner
l*******m@mirati.com
-
Roch Switlik
Head Of Supply Chain Management
r**h@mirati.com
-
Stephen K Lee
Associate Director
l**s@mirati.com
-
Augustine Bourne
a*****e@mirati.com
-
Lisa Trapp
Senior Director, Finance
l****p@mirati.com
-
General Inquiries
info@mirati.com
-
Unclassified inbox
marounc@mirati.com
-
Unclassified inbox
christensenj@mirati.com
-
Unclassified inbox
clemasters@mirati.com
-
Unclassified inbox
lemastersc@mirati.com
-
Unclassified inbox
heldn@mirati.com
NeoGenomics
NeoGenomics is a cancer reference laboratory that Show more...provides cancer testing and partnership programs to pathologists and oncologists.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: Oct 29, 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NEO
Operating Status: Active
12 Emails
0 Phones
Main email format: sarah.smith@neogenomics.com (60.0%)
-
Ryan J Angell
Vice President, Oncology Services and Laboratory Collaborations
r*****l@neogenomics.com
-
David S Brooks
Divisional Vice President, Informatics
d*****s@neogenomics.com
-
Ricky Kleinsmith
Associate Director of Quality Management Systems
r*********h@neogenomics.com
-
Lakshmi Chandramohan
Principal Scientist, Associate Director, Molecular Assay Services
l***********n@neogenomics.com
-
Sharon Kaufman
s************n@neogenomics.com
-
First Last
f********t@neogenomics.com
-
Kendra Sweeney
k************y@neogenomics.com
-
Unclassified inbox
aimee.bui@neogenomics.com
-
Human Resources Team
HR@neogenomics.com
-
Human Resources Team
hr@neogenomics.com
-
Unclassified inbox
sjones@neogenomics.com
-
Unclassified inbox
sagersborg@neogenomics.com
Syneos Health
Syneos Health, the only fully integrated end-to-enShow more...d clinical and commercial solution organization.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Secondary
Last Investment Activity: Jan 12, 2024
Founded Date: 1985
Company Type: For Profit
Stock Symbol: NASDAQ:SYNH
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@syneoshealth.com (100.0%)
-
Ian Dorrian
President Communications Europe
i*********n@syneoshealth.com
-
Sean Wallace
Clinical Technician
s**********e@syneoshealth.com
-
Elgin C Duckery
District Sales Manager
e***********y@syneoshealth.com
-
Aparna Sree
Talent Acquisition Spec II
a******p@syneoshealth.com
-
Agnieszka Mazek
International Corporate Recruiter II
a*************k@syneoshealth.com
-
Anita Burroughs
a*************s@syneoshealth.com
-
Susanna Giorgi
s************i@syneoshealth.com
-
Career Opportunities
jobs@syneoshealth.com
-
Unclassified inbox
abcdefghij@syneoshealth.com
-
Unclassified inbox
toby.marshall@syneoshealth.com
-
Unclassified inbox
corporatehumanresources@syneoshealth.com
-
General Inquiries
info@syneoshealth.com
-
Unclassified inbox
xxxx@syneoshealth.com
ALK Abelló
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Mar 4, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Louise Dahlgaard
Senior Global Pricing Manager
l**************d@alk-abello.com
-
Connie Kristiansen
c****************n@alk-abello.com
-
Martin Rud Pedersen
Acting Senior Vice President, Global Clinical Development
m*************n@alk-abello.com
-
Manuel Lombardero
Director CMC Development
m***************o@alk-abello.com
-
Kristina Benedict
k***************t@alk-abello.com
-
Josephine Licht
Chemist
j*************t@alk-abello.com
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com
-
Unclassified inbox
cgndk@alk-abello.com
-
Unclassified inbox
domingo.barber@alk-abello.com
-
Unclassified inbox
drugsafetyuk@alk-abello.com
-
Unclassified inbox
ameno@alk-abello.com
-
Unclassified inbox
infouk@alk-abello.com
West Pharmaceutical Services
West Pharmaceutical Services is a manufacturer of Show more...technologically advanced containment and delivery systems for injectable medicines.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Jun 21, 2024
Founded Date: 1923
Company Type: For Profit
Stock Symbol: NYSE:WST
Operating Status: Active
14 Emails
0 Phones
Main email format: sarah.smith@westpharma.com (100.0%)
-
Rick Phelan
Information Technology, Sr. Director
r*********n@westpharma.com
-
Theodore Weir
Med Device & Pharma Program Manager
t***********r@westpharma.com
-
Séamus Kilbane
s************e@westpharma.com
-
Atul Patel
Vice President, Devices & Delivery Systems
a********l@westpharma.com
-
Preety Lall
p*********l@westpharma.com
-
Delphine Vanacker
d***************r@westpharma.com
-
Graham Sattler
g************r@westpharma.com
-
Unclassified inbox
John.Sweeney@westpharma.com
-
Unclassified inbox
lynn.lundy@westpharma.com
-
Unclassified inbox
Kimberly.MacKay@westpharma.com
-
Customer Service
westpharmaceuticalservices@westpharma.com
-
Unclassified inbox
hr.singapore@westpharma.com
-
Unclassified inbox
yap.kengsiang@westpharma.com
-
Unclassified inbox
safetysystems@westpharma.com
Alkermes
Alkermes is a biotechnology company that develops,Show more... manufactures and commercializes medicines for the treatment of chronic diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 22, 2024
Founded Date: 1987
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ALKS
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@alkermes.com (100.0%)
-
Anne Tremmel
Hospital Business Manager
a**********l@alkermes.com
-
Patricia Hedrick
Senior Production Planner
p**************k@alkermes.com
-
Robin Kleiman
Vice President, CNS Biology
r***********n@alkermes.com
-
Leah Goodnight
Director, Thought Leader Engagement
l************t@alkermes.com
-
Patrick Laclair
Director, Commercial Contract Operations
p*************r@alkermes.com
-
Ingo Mugge
i********e@alkermes.com
-
Julie Graham
j**********m@alkermes.com
-
Unclassified inbox
busdev@alkermes.com
-
Unclassified inbox
christy.burchett@alkermes.com
-
Unclassified inbox
brian.blood@alkermes.com
ALK Abelló
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 27, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Louise Dahlgaard
Senior Global Pricing Manager
l**************d@alk-abello.com
-
Connie Kristiansen
c****************n@alk-abello.com
-
Martin Rud Pedersen
Acting Senior Vice President, Global Clinical Development
m*************n@alk-abello.com
-
Manuel Lombardero
Director CMC Development
m***************o@alk-abello.com
-
Kristina Benedict
k***************t@alk-abello.com
-
Josephine Licht
Chemist
j*************t@alk-abello.com
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
Giant Eagle
Giant Eagle is a national supermarket chain with sShow more...ome of their own brands of products.
Specialized In: Technology & Software, Food Delivery, Pharmaceuticals, E-commerce & Retail
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 12, 2024
Founded Date: 1931
Company Type: For Profit
Operating Status: Active
8 Emails
1 Phones
Main email format: sarah.smith@gianteagle.com (100.0%)
-
Bill Artman
President
b*********n@gianteagle.com
-
Vincent Donofrio
Front End Operations Manager, East Divison
v**************o@gianteagle.com.If
4********1
-
Grocery Manager
grocery
g******************0@gianteagle.com
-
Gary Hay
Chief Technology Officer
g******y@gianteagle.com
-
Susan Raderridgeway
Regional Facilities Manager
s*****************y@gianteagle.com
-
Chris Forde
Sr. Category Manager, Dairy
c*********e@gianteagle.com
-
Daniela Mayol
d***********l@gianteagle.com
-
Unclassified inbox
gianteaglerx@mscripts.com
InVivo
InVivo helps agriculture cooperation regain their Show more...rightful place in the global food value chain.
Specialized In: AgTech, Pharmaceuticals, Healthcare & Medical
Business Type: Private
Employees: 5001-10000
Rounds: Private Equity
Last Investment Activity: Mar 5, 2024
Founded Date: 1945
Company Type: For Profit
Operating Status: Active
16 Emails
0 Phones
Main email format: ssmith@invivo-group.com (83.3%)
-
Maha Fournier
Group Chief Financial and Operating Officer
m*******r@invivo-group.com
-
Nathalie BAROTTE
Gestionnaire de carrières & RRH International
n******e@invivo-group.com
-
Edouard Lanckriet
e********t@invivo-group.com
-
Romain Affanni
r******i@invivo-group.com
-
Delphine CAMUS
d****s@invivo-group.com
-
Thierry Blandinières
Chief Executive Officer & Founder
t*****y@invivo-group.com
-
General Inquiries
info@invivo-group.com
-
Admin Team
admin@invivo-group.com
-
Customer Service
support@invivo-group.com
-
General Inquiries
contact@invivo-group.com
-
Sales Department
sales@invivo-group.com
-
Unclassified inbox
phamelin@invivo-group.com
-
Unclassified inbox
mciarlet@invivo-group.com
-
Unclassified inbox
sjuin@invivo-group.com
-
Unclassified inbox
invivo-logistique-stockage@invivo-group.com
-
Unclassified inbox
pbouillard@invivo-group.com
Ipsen
Ipsen is a global specialty-driven biopharmaceuticShow more...al company focused on innovation and specialty care.
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 25, 2024
Founded Date: 1929
Number of Exits: 5
Company Type: For Profit
Stock Symbol: EPA:IPN
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@ipsen.com (100.0%)
-
Sandra Silvestri
EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety & Patient Affairs
s**************i@ipsen.com
-
Susan Tinney
s**********y@ipsen.com
-
Karen Hummel
Executive Director, National Health Systems, Medical Affairs
k**********l@ipsen.com
-
Helen Hsu
h*******u@ipsen.com
-
Katarzyna Wegner
k**************r@ipsen.com
-
Charitable Contributionsna
c************************a@ipsen.com
-
Unclassified inbox
Clinical.trials@ipsen.com
-
Unclassified inbox
corporate.communications@ipsen.com
-
Unclassified inbox
qualitycomplaints.russia.cis@ipsen.com
-
Unclassified inbox
ipsenepe@ipsen.com
-
Unclassified inbox
medical.information.russia.cis@ipsen.com
-
Unclassified inbox
medinfo.uk-ie@ipsen.com
-
Unclassified inbox
contact.web@ipsen.com
-
Unclassified inbox
pierre-et.chabrier@ipsen.com
-
Unclassified inbox
yves.christen@ipsen.com
-
Unclassified inbox
ipsennadigital@ipsen.com
Sanofi
Sanofi is a healthcare company that provides treatShow more...ments and the protection of life-saving vaccines.
Specialized In: Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 21, 2024
Founded Date: 1973
Number of Exits: 12
Company Type: For Profit
Stock Symbol: NYSE:SNY
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@sanofi.com (83.3%)
-
Patricia Roselle
Global Head, Patient Network Management
p*************e@sanofi.com
-
Guy Griebel
Senior Director Sanofi Genzyme Neuroscience
g*********l@sanofi.com
-
Anne Dulac-Gaume
Corporate Business Development - Director
a*************e@sanofi.com
-
Laith Elkurd
l**********d@sanofi.com
-
Nkazakhstan Pharmacovigilance
n***************************e@sanofi.com
-
20bernhard Lebic
2**************c@sanofi.com
-
Unclassified inbox
caio.inbox@sanofi.com
-
Customer Service
customersupport@sanofi.com
-
Unclassified inbox
hongbingzhang@sanofi.com
-
Unclassified inbox
kim@sanofi.com
Shionogi
Shionogi is a pharmaceutical company that offers pShow more...harmaceuticals, diagnostic reagents, and medical devices.
Specialized In: Biotechnology, Medical Devices, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Feb 27, 2024
Founded Date: Mar 17, 1878
Number of Exits: 3
Company Type: For Profit
Stock Symbol: TYO:4507
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@shionogi.com (60.0%)
-
Donald Pirkl
Supplier Manager
d****l@shionogi.com
-
Calvin Smith
Key Account Manager
c****h@shionogi.com
-
Fabio De Gregorio
f*********o@shionogi.com
-
Sol Yates
s****s@shionogi.com
-
Laura Littleton
l*************n@shionogi.com
-
Danielle Lewis
d************s@shionogi.com
-
Unclassified inbox
ShionogiCommunications@shionogi.com
-
General Inquiries
contact@shionogi.eu
-
General Inquiries
info@shionogi.co.jp
-
Unclassified inbox
aaralihalli@shionogi.com
-
Unclassified inbox
corporatecommunications@shionogi.com
BridgeBio
BridgeBio focuses on the development and commerciaShow more...lization of precision medicines for various genetic diseases and cancers.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: 2015
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:BBIO
Operating Status: Active
14 Emails
0 Phones
Main email format: ssmith@bridgebio.com (66.7%)
-
Neil Kumar
Co-Founder & CEO
n********r@bridgebio.com
-
Neil Kumar
Co-Founder & CEO
n****r@bridgebio.com
-
Thomas Parker
Scientist II - MSAT Lead
t*****r@bridgebio.com
-
Jennifer Hodge
j****e@bridgebio.com
-
Brian Stephenson
b*********n@bridgebio.com
-
Academic Research
a***************h@bridgebio.com
-
General Inquiries
info@bridgebio.com
-
Customer Service
support@bridgebio.com
-
Management Department
manager@bridgebio.com
-
General Inquiries
contact@bridgebio.com
-
Sales Department
sales@bridgebio.com
-
Unclassified inbox
mp@bridgebio.com
-
Unclassified inbox
mh@bridgebio.com
-
Unclassified inbox
vb@bridgebio.com
Cullinan Oncology
Cullinan Oncology is a developer of an externally Show more...sourced cancer therapeutics used to end a drug program quickly.
Specialized In: Pharmaceuticals, Biotechnology, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 2017
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEM
Operating Status: Active
12 Emails
0 Phones
Main email format: ssmith@cullinanoncology.com (100.0%)
-
Corinne Savill
Chief Business Officer
c*****l@cullinanoncology.com
-
Nadim Ahmed
President and CEO
n****d@cullinanoncology.com
-
Jennifer Michaelson
Chief Development Officer
j*********n@cullinanoncology.com
-
Leslie Mariani
Vice President, Finance and Operations
l******i@cullinanoncology.com
-
Jeffrey Trigilio
Chief Financial Officer
j*******o@cullinanoncology.com
-
Sal Firicano
VP and Head of Information Technology
s*******o@cullinanoncology.com
-
General Inquiries
info@cullinoncology.com
-
General Inquiries
contact@cullinanoncology.com
-
Unclassified inbox
klagueerre@cullinanoncology.com
-
Unclassified inbox
u003erhickey@cullinanoncology.com
-
Unclassified inbox
privacy@cullinanoncology.com
-
Unclassified inbox
filn@cullinanoncology.com
Evotec
Evotec is a pharmaceutical and life science companShow more...y that provides drug discovery and gene therapy solutions.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: 1993
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:EVO
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@evotec.com (83.3%)
-
Benedict Chen
Vice President
b***********n@evotec.com
-
Alessandro Orsetti
a****************i@evotec.com
-
Alex Jakober
Sr Systems Engineer
a**********r@evotec.com
-
Christopher W.
IT Group Leader Site Services
c***********w@evotec.com
-
Patrice Douillard
p***************d@evotec.com
-
Magnus Schroeder
m**************r@evotec.com
-
General Inquiries
info@evotec.com
-
Unclassified inbox
zoe.collins@evotec.com
-
Unclassified inbox
heinz.vonderkammer@evotec.com
-
Unclassified inbox
panhunter@evotec.com
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the developmeShow more...nt of various products for the treatment of rare and ultra-rare diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Feb 26, 2024
Founded Date: 2010
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:RARE
Operating Status: Active
14 Emails
0 Phones
Main email format: ssmith@ultragenyx.com (83.3%)
-
John Klock
Founder
j**n@ultragenyx.com
-
Jung Cho
Associate Director of Validation
j**o@ultragenyx.com
-
Akhilesh Bhambhani
Sr. Director, Biologics Drug Product Development- Tech Dev/Tech Ops
a********i@ultragenyx.com
-
Marisa Capponi
Associate Director
m******i@ultragenyx.com
-
Benjamin Ehrhart
Vice President, Assistant General Counsel
b******t@ultragenyx.com
-
Xiaohui Lu
Senior Research Scientist
x*u@ultragenyx.com
-
General Inquiries
info@ultragenyx.com
-
Unclassified inbox
trialrecruitment@ultragenyx.com
-
Unclassified inbox
MCorley@ultragenyx.com
-
Investor Relations
higair@ultragenyx.com
-
Media Relations
blakemedia@ultragenyx.com
-
Unclassified inbox
ekakkis@ultragenyx.com
-
Unclassified inbox
gcapiaux@ultragenyx.com
-
Unclassified inbox
mwhetstone@ultragenyx.com
Fosun Pharma
Fosun Pharma is a pharmaceutical company.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Debt Financing
Last Investment Activity: Mar 14, 2024
Founded Date: 1994
Number of Exits: 11
Company Type: For Profit
Stock Symbol: HKG:2196
Operating Status: Active
Investor Type: Venture Capital
17 Emails
0 Phones
Main email format: smiths@fosunpharma.com (83.3%)
-
Qiyu Chen
Executive Director , Chairman of the Board
c***q@fosunpharma.com
-
Aimin Hui
Executive Presendent of Fosun Pharma; President of Global R&D, Chief Medical Officer
h**a@fosunpharma.com
-
Lijun Wu
CSO of Fosun Pharma / Founder and Head of FUSION Bioventure
w*l@fosunpharma.com
-
Alex Zhu
Executive Director
z**a@fosunpharma.com
-
Zhu Xi
z*u@fosunpharma.com
-
Mike Xu
Co-President
x*m@fosunpharma.com
-
Investor Relations
ir@fosunpharma.com
-
Unclassified inbox
info.usa@fosunpharma.com
-
Unclassified inbox
fosunpharma@wsfg.hk
-
Unclassified inbox
int@fosunpharma.com
-
Unclassified inbox
LastF@fosunpharma.com
-
Unclassified inbox
lianzhengdc@fosunpharma.com
-
Unclassified inbox
hueq@fosunpharma.com
-
Unclassified inbox
xut@fosunpharma.com
-
Human Resources Team
adgenvax.hr@fosunpharma.com
-
Unclassified inbox
yangchen2@fosunpharma.com
-
Unclassified inbox
jszhiliang@fosunpharma.com
Rakuten Medical
Rakuten Medical is a biotechnology company that deShow more...velops precision, cell-targeting investigational therapies.
Specialized In: Pharmaceuticals, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 101-250
Rounds: Series E
Last Investment Activity: Mar 26, 2024
Founded Date: 2010
Company Type: For Profit
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@rakuten-med.com (50.0%)
-
Natalie Huang
People Operations Generalist (HR)
n****g@rakuten-med.com
-
Shashank Basavaraju
Associate Manager, Technical Operations & Global Supply Chain
s*********u@rakuten-med.com
-
Carlos A Garcia
Chief Technical Officer
c*****a@rakuten-med.com
-
Kazuo Nagamatsu
k*************u@rakuten-med.com
-
Mathieu Oulevey
m*************y@rakuten-med.com
-
Unclassified inbox
info.tw@rakuten-med.com
-
Unclassified inbox
j.d@rakuten-med.com
-
General Inquiries
info@rakuten-med.com
-
General Inquiries
clinicaltrialsinfo@rakuten-med.com
-
Unclassified inbox
info.jp@rakuten-med.com
Debiopharm Group
Debiopharm Group is a biopharmaceutical developmenShow more...t specialist that in-licenses promising biologics and small molecule drug.
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices, Pharmaceuticals
Business Type: Private
Employees: 501-1000
Rounds: Grant
Last Investment Activity: Sep 28, 2023
Founded Date: 1979
Number of Exits: 6
Company Type: For Profit
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@debiopharm.com (100.0%)
-
Patrick Garrouste
p***************e@debiopharm.com
-
Valerie Blasco
v************o@debiopharm.com
-
Claire Laprun
c***********n@debiopharm.com
-
U003edawn Bonine
u**************e@debiopharm.com
-
David Cameron
d***********n@debiopharm.com
-
Unclassified inbox
communication@debiopharm.com
-
Unclassified inbox
mwagner@debiopharm.com
-
Unclassified inbox
mmurone@debiopharm.com
-
Unclassified inbox
mbarbier@debiopharm.com
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical companShow more...y with one approved product.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Jan 16, 2024
Founded Date: 1996
Company Type: For Profit
Stock Symbol: NASDAQ:TBPH
Operating Status: Active
13 Emails
0 Phones
Main email format: ssmith@theravance.com (100.0%)
-
Christopher Porter
Vice President, Development Strategy and Innovation
c*****r@theravance.com
-
Kerry Zampa
Head, Global Learning & Organization Development
k****a@theravance.com
-
Venkat Vutukuri
BI Analytics Lead Architect
v*******i@theravance.com
-
Punam Shaida
p*****a@theravance.com
-
Jesse Fecker
Senior Director, Chief US Patent Counsel
j*****r@theravance.com
-
General Inquiries
medinfo@theravance.com
-
General Press Inquiries
cypress@theravance.com
-
Investor Relations
investor.relations@theravance.com
-
Unclassified inbox
rwinningham@theravance.com
-
Unclassified inbox
wmartin@theravance.com
-
Unclassified inbox
ibdstudies@theravance.com
-
Unclassified inbox
amiller@theravance.com
-
Unclassified inbox
tguerin@theravance.com
Alvogen
Alvogen is a manufacturer of pharmaceutical products.
Specialized In: Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Rounds: Private Equity
Last Investment Activity: Feb 3, 2023
Founded Date: 2009
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@alvogen.com (100.0%)
-
Kristin Hulda Sverrisdottir
Executive PA to the Chairman and CEO of Alvogen
k*******************r@alvogen.com
-
jasmine shah
VP MA and RA
j**********h@alvogen.com
-
Ripal Gaudana
Principal Scientist ( Product Development)
r***********a@alvogen.com
-
Mark Decesare
m***********e@alvogen.com
-
Lisa Elvin
l********n@alvogen.com
-
General Inquiries
info@alvogen.com
-
General Inquiries
ithelp@alvogen.com
-
Unclassified inbox
joe.miller@alvogen.com
Mankind Pharma
Mankind Pharma is a pharmaceutical company that deShow more...velops, commercializes, and delivers medicines for urgent medical needs.
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Secondary Market
Last Investment Activity: Mar 11, 2024
Founded Date: 1995
Company Type: For Profit
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@mankindpharma.com (100.0%)
-
Eklavya Juneja
e************a@mankindpharma.com
-
Sarah Bhambre
s***********e@mankindpharma.com
-
Dilip Chaturvedi
d**************i@mankindpharma.com
-
Paridhi Mathur
p************r@mankindpharma.com
-
Sandip Mitra
s**********a@mankindpharma.com
-
General Inquiries
contact@mankindpharma.com
-
Unclassified inbox
singhania@mankindpharma.com
-
Unclassified inbox
tanu@mankindpharma.com
-
Unclassified inbox
xxxx@mankindpharma.com
Zai Lab
Zai Lab brings transformative medicines for cancerShow more..., autoimmune, and infectious diseases to patients in China and around the world.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 6, 2024
Founded Date: 2014
Company Type: For Profit
Stock Symbol: NASDAQ:ZLAB
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@zailaboratory.com (100.0%)
-
Peter Huang
Chief Scientific Officer
p*********g@zailaboratory.com
-
Karl Hsu
Senior Vice President, Clinical Research and Early Development
k******u@zailaboratory.com
-
6943ronald Aldridge
6*****************e@zailaboratory.com
-
5011danielle Halstrom
5*******************m@zailaboratory.com
-
6943lina Zhang
6************g@zailaboratory.com
-
General Inquiries
info@zailaboratory.com
-
Admin Team
admin@zailaboratory.com
-
Customer Service
support@zailaboratory.com
-
Legal Department
legal@zailaboratory.com
-
Unclassified inbox
bd@zailaboratory.com
-
Human Resources Team
hr@zailaboratory.com
Eagle Pharmaceuticals
Eagle Pharmaceuticals is a company focused on deveShow more...loping and commercializing injectable products in the critical care and oncology areas.
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics, Pharmaceuticals
Business Type: Public
Employees: 101-250
Rounds: Venture - Series Unknown
Last Investment Activity: May 22, 2024
Founded Date: 2007
Company Type: For Profit
Stock Symbol: NASDAQ:EGRX
Operating Status: Active
14 Emails
0 Phones
Main email format: ssmith@eagleus.com (100.0%)
-
Jorma Lalla
Vice President
j****a@eagleus.com
-
Brendan Killeen
Regional Sales Director
b******n@eagleus.com
-
David S Bricker
Vice President, Head Global Manufacturing and Supply
d******r@eagleus.com
-
Alan Eagle
a****e@eagleus.com
-
Daniel Maher
d****r@eagleus.com
-
General Inquiries
info@eagleus.com
-
Unclassified inbox
aelgohail@eagleus.com
-
Unclassified inbox
jlarocca@eagleus.com
-
Unclassified inbox
egrx@openboard.info
-
Unclassified inbox
rsvp@eagleus.com
-
Unclassified inbox
mlegiec@eagleus.com
-
Unclassified inbox
doconnor@eagleus.com
-
Unclassified inbox
kmartin@eagleus.com
-
Unclassified inbox
faith@eagleus.com
Par Pharmaceuticals
Par Pharmaceutical develops, manufactures, and marShow more...kets innovative and cost-effective generic pharmaceutical products.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Last Investment Activity: Jun 28, 2019
Founded Date: 1978
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@parpharm.com (75.0%)
-
Richard Carlson
c*******d@parpharm.com
-
Jason Rose
j***e@parpharm.com
-
Karam Razooq
k**********q@parpharm.com
-
Marie-Louise Mansour
m******************r@parpharm.com
-
Delpapa Paula
d***********a@parpharm.com
-
Unclassified inbox
cs.formulations@parpharm.com
-
Unclassified inbox
Thomas.Haughey@parpharm.com
-
Unclassified inbox
john.smith@parpharm.com
-
Unclassified inbox
swenzel@parpharm.com
-
Unclassified inbox
starrif@parpharm.com
Medpace
Medpace, Inc., a clinical research organization, pShow more...rovides clinical development services for pharmaceutical and biotechnology
Specialized In: Biotechnology, Pharmaceuticals
Acquired by: Cinven
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 12, 2024
Founded Date: 1992
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:MEDP
Operating Status: Active
6 Emails
1 Phones
Main email format: s.smith@medpace.com (100.0%)
-
Guido Moesker
Sr. Director Clinical Trial Management
g*******r@medpace.com
-
Angela White
Clinical Trial Manager
a*****e@medpace.com.If
2********2
-
Estelle Stephan
e*******n@medpace.com
-
Kelsey Neal
Quality Assurance Auditor
k****l@medpace.com
-
Serena Acquati
s*******i@medpace.com
-
General Inquiries
info@medpace.com
Unither Pharmaceuticals
Unither Pharmaceuticals is a French manufacturer oShow more...f dosage forms for pharmaceutical laboratories and generic products.
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Acquired by: Ardian
Business Type: Private
Employees: 1001-5000
Rounds: Private Equity
Last Investment Activity: Jul 2, 2024
Founded Date: 1993
Company Type: For Profit
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@unither-pharma.com (100.0%)
-
Perrine Millereux
Human Resources Manager
p***************x@unither-pharma.com
-
Olivier Bellot
o************t@unither-pharma.com
-
Kevin Colangelo
General Manager North America Unither Pharmacuiticals
k*************o@unither-pharma.com
-
Adeline Croisy
a************y@unither-pharma.com
-
Fanny Guillemin
f*************n@unither-pharma.com
-
Admin Team
admin@unither-pharma.com
-
General Inquiries
contact@unither-pharma.com
-
Unclassified inbox
unither@unither-pharma.com
-
Unclassified inbox
kathleen.slocum@unither-pharma.com
-
Unclassified inbox
anthony.reda@unither-pharma.com
-
Unclassified inbox
rui.jin@unither-pharma.com
H.C. Starck
H.C. Starck develops, produces, and markets metallShow more...ic and ceramic powders, and fabricated products.
Specialized In: Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Acquired by: MASAN Group
Business Type: Private
Employees: 1001-5000
Last Investment Activity: Jul 15, 2022
Founded Date: 1940
Company Type: For Profit
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@hcstarck.com (100.0%)
-
Allen Losinski
a************i@hcstarck.com
-
Joshua Mattos
j***********s@hcstarck.com
-
Rudy Noble
l*********g@hcstarck.com
-
Lars Gniffke
l**********e@hcstarck.com
-
Peter Zhang
p*********g@hcstarck.com
-
General Inquiries
info@hcstarck.com
-
Customer Service
support@hcstarck.com
-
General Inquiries
contact@hcstarck.com
-
Unclassified inbox
hcstarck@prpetuum.de
-
Unclassified inbox
kate.mastroianni@hcstarck.com
-
Unclassified inbox
bewerbermanagement@hcstarck.com
Angion
Angion Biomedica is a clinical stage organ restoraShow more...tion biopharmaceutical company focused on renal disease.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2023
Founded Date: 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:ANGN
Operating Status: Closed
8 Emails
2 Phones
Main email format: ssmith@angion.com (75.0%)
-
Jay Venkatesan
President, Chief Executive Officer and Director
j*********n@angion.com
-
Jay Venkatesan
President, Chief Executive Officer and Director
j*y@angion.com
*************1
-
Itzhak Goldberg
Founder
i*******g@angion.com
-
Weizhong Cai
VP Drug Development
w**i@angion.com
-
Legal Department
legal@angion.com
-
General Inquiries
mail@angion.com
-
Investor Relations
affairsinvestors@angion.com
-
Unclassified inbox
bdupee@angion.com
MediGene
MediGene is a company that specializes in biotechnShow more...ology specifically in the treatment of cancer.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Mar 4, 2024
Founded Date: 1994
Company Type: For Profit
Stock Symbol: ETR:MDG1
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@medigene.com (75.0%)
-
Pamela Keck
Vice President of Investor Relations and Corporate Communications
p*********k@medigene.com
-
Medigene Comcorpdev
m*****************v@medigene.com
-
Gerrit Brandt
Director Accounting and Controlling
g******t@medigene.com
-
Dolores Schendel
Chief Scientific Officer and Managing Director
d**************l@medigene.com
-
Investor Relations
investor@medigene.com
-
Unclassified inbox
medigene@medigene.com
-
Unclassified inbox
u.moebius@medigene.com
-
Unclassified inbox
b.koehler@medigene.com
-
Unclassified inbox
corpdev@medigene.com
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing tShow more...o market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Jan 23, 2024
Founded Date: 1979
Company Type: For Profit
Stock Symbol: NASDAQ:INO
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@inovio.com (75.0%)
-
Jennifer Laux
Vice President, Marketing
j******r@inovio.com
-
Jennie Willson
j************n@inovio.com
-
U003ejennie Willson
u*****************n@inovio.com
-
U003ethomas Hong
u**************g@inovio.com
-
Unclassified inbox
jennie.willson@inovio.com
-
Unclassified inbox
ino@inovio.com
-
Unclassified inbox
mbagarazzi@inovio.com
-
Unclassified inbox
nsardesai@inovio.com
Biohaven Pharmaceutical
Biohaven is a biopharmaceutical company that develShow more...ops drug candidates targeting neurological diseases.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Apr 17, 2023
Founded Date: 2013
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NYSE:BHVN
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@biohavenpharma.com (100.0%)
-
Matt Buten
Chief Financial Officer
m********n@biohavenpharma.com
-
Mike Messina
m**********a@biohavenpharma.com
-
Chris White
c*********e@biohavenpharma.com
-
Missy Rector
m**********r@biohavenpharma.com
-
Unclassified inbox
rob@biohavenpharma.com
-
Unclassified inbox
vlad.coric@biohavenpharma.com
-
Unclassified inbox
last@biohavenpharma.com
-
Unclassified inbox
jim.engelhart@biohavenpharma.com
Scilex Holding Company
Scilex Pharmaceuticals is an emerging pharmaceuticShow more...al company focused on acquiring and commercializing late-stage prescription products.
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1-10
Rounds: Post-IPO Equity
Last Investment Activity: Mar 2, 2024
Founded Date: 2012
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SCLX
Operating Status: Active
8 Emails
1 Phones
Main email format: ssmith@scilexholding.com (100.0%)
-
Jaisim Shah
CEO & President, Director,CEO & Director, Scilex Holding
j***h@scilexholding.com
-
David J Tarin
Territory Business Manager
d****n@scilexholding.com
-
Jonathan Perkins
Territory Business Manager
j******s@scilexholding.com
-
Chris Ippolito
c*******o@scilexholding.com
-
General Inquiries
info@scilexholding.com
-
General Inquiries
info@scilexpharma.com
-
Unclassified inbox
investorrelations@scilexholding.com
-
Unclassified inbox
u003einvestorrelations@scilexholding.com
AeroSafe Global
AeroSafe Global develops aerogels used in various Show more...transport, biomedical, pharmaceutical, and other temperature-sensitive products.
Specialized In: Pharmaceuticals, Manufacturing & Industrial
Business Type: Private
Employees: 51-100
Rounds: Private Equity
Last Investment Activity: Nov 28, 2023
Founded Date: 1995
Company Type: For Profit
Operating Status: Active
10 Emails
0 Phones
Main email format: ssmith@aerosafeglobal.com (100.0%)
-
David Cortese
Director, Engineering and Automation
d******e@aerosafeglobal.com
-
Kelley Rowan
Human Resources Generalist
k****n@aerosafeglobal.com
-
Alan J Krokenberger
Director Of Engineering
a***********r@aerosafeglobal.com
-
Danner Hickman
Director Corporate Development
d******n@aerosafeglobal.com
-
General Inquiries
info@aerosafeglobal.com
-
Customer Service
support@aerosafeglobal.com
-
General Inquiries
info@americanaerogel.com
-
Unclassified inbox
diane.knight@aerosafeglobal.com
-
Unclassified inbox
sean.herdlein@aerosafeglobal.com
-
Unclassified inbox
mrinaldi@aerosafeglobal.com
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology compaShow more...ny that focuses on the development of medicine to treat diseases with a genetic origin.
Specialized In: Biotechnology, Healthcare & Medical, Technology & Software, Pharmaceuticals
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 7, 2024
Founded Date: 1989
Company Type: For Profit
Stock Symbol: NASDAQ:ARWR
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@arrowheadpharma.com (100.0%)
-
Bruce Given
Chief Operating Officer
b****n@arrowheadpharma.com
-
Holly Hamilton
Associate Director, Bioassays
h*******n@arrowheadpharma.com
-
Matthew Cyr
Postbaccalaureate Fellow
m**r@arrowheadpharma.com
-
Ken Myszkowski
Chief Financial Officer
k*********i@arrowheadpharma.com
-
General Inquiries
info@arrowheadpharma.com
-
Legal Department
legal@arrowheadpharma.com
-
General Inquiries
info@arrowres.com
-
Unclassified inbox
dlewis@arrowheadpharma.com
-
Unclassified inbox
careers@arrowheadpharma.com
-
Unclassified inbox
mguokas@arrowheadpharma.com
-
Unclassified inbox
vanzalone@arrowheadpharma.com
BTG International
BTG is a global healthcare company focused on InteShow more...rventional Medicine.
Specialized In: Pharmaceuticals, Hospitals & Clinics, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jan 27, 2020
Founded Date: 1948
Number of Exits: 2
Company Type: For Profit
Operating Status: Closed
9 Emails
0 Phones
Main email format: sarah.smith@btgplc.com (66.7%)
-
Darby Citizen Kane
National Sales Manager Acute Care
d********e@btgplc.com
-
Richard Skellie
r*******e@btgplc.com
-
Joe Neale
Chief Technology Officer & Head of Respiratory Innovation Center
j*******e@btgplc.com
-
Nmartin Sandford
n**************d@btgplc.com
-
Customer Service
customerservice@btgplc.com
-
General Inquiries
ninfo@btgplc.com
-
Unclassified inbox
simon.bunegar@btgplc.com
-
Unclassified inbox
elizabeth.gallagher@btgplc.com
-
Unclassified inbox
info.us@btgplc.com
Galapagos
Galapagos is a clinical-stage biotechnology companShow more...y, specialized in the discovery and development of small molecule medicines with novel.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 25, 2024
Founded Date: 1999
Company Type: For Profit
Stock Symbol: VIE:GLPG
Operating Status: Active
12 Emails
0 Phones
Main email format: sarah.smith@glpg.com (100.0%)
-
Werner Cautreels
Director
w**************s@glpg.com
-
Francois Normant
Director Human Resources France
f**************t@glpg.com
-
Raphaëlle LACHAT
r**************t@glpg.com
-
Esther Otinwa-ext
e***************t@glpg.com
-
General Inquiries
info@glpg.com
-
Customer Service
support@glpg.com
-
Legal Department
legal@glpg.com
-
Unclassified inbox
dpo@glpg.com
-
Investor Relations
63ir@glpg.com
-
Media Relations
603media@glpg.com
-
Unclassified inbox
reginald.brys@glpg.com
-
Unclassified inbox
lien.lepescheux@glpg.com
Ligand Pharmaceuticals
Ligand is a biopharmaceutical company focused on dShow more...eveloping or acquiring technologies that help pharmaceutical companies.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: Sep 1, 1987
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:LGND
Operating Status: Active
13 Emails
0 Phones
Main email format: ssmith@ligand.com (66.7%)
-
John L. Higgins
CEO
j******s@ligand.com
-
Ram Kapil
Senior Director, Clinical Pharmacology
r****l@ligand.com
-
Jessica Wolzen
Associate Director, Regulatory & Operations
j******w@ligand.com
-
Paul Hadden
Managing Director
p*****n@ligand.com
-
General Inquiries
info@ligand.com
-
Admin Team
admin@ligand.com
-
General Inquiries
contact@ligand.com
-
Career Opportunities
jobs@ligand.com
-
Media Relations
media@ligand.com
-
Unclassified inbox
galiprandi@ligand.com
-
Unclassified inbox
jsharp@ligand.com
-
Unclassified inbox
jfanno@ligand.com
-
Unclassified inbox
careers@ligand.com
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotShow more...echnology company developing novel cellular therapies to treat unmet medical needs.
Specialized In: Pharmaceuticals, Biotechnology, Coaching & Consulting, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 6, 2024
Founded Date: Jan 1, 1990
Number of Exits: 1
Company Type: For Profit
Stock Symbol: TLV:BTX
Operating Status: Active
10 Emails
0 Phones
Main email format: ssmith@lineagecell.com (100.0%)
-
Jill Howe
Chief Financial Officer
j***e@lineagecell.com
-
Brian Culley
Chief Executive Officer at BioTime, Inc. (NYSE:BTX)
b*****y@lineagecell.com
-
Dan Giles
Business Development Manager
d****s@lineagecell.com
-
Aleksandra Jovanovic Poole
Vice President, Product Development
a****e@lineagecell.com
-
General Inquiries
info@lineagecell.com
-
General Inquiries
contact@lineagecell.com
-
Legal Department
legal@lineagecell.com
-
Investor Relations
ir@lineagecell.com
-
Unclassified inbox
rsingh@lineagecell.com
-
Unclassified inbox
fbinette@lineagecell.com
Myriad Genetics
Myriad Genetics discovers, develops, and commerciaShow more...lizing novel therapies for the treatment of cancer.
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 1991
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:MYGN
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@myriad.com (75.0%)
-
Patrick Burke
EVP of Strategy and Innovation
p***********e@myriad.com
-
Dale Muzzey
Vice President of Bioinformatics
d*****y@myriad.com
-
Matt Scalo
m********o@myriad.com
-
Nick Collins
n**********s@myriad.com
-
General Inquiries
info@myriad.com
-
Investor Relations
investor@myriad.com
-
Customer Service
support@myriad.com
-
General Inquiries
contact@myriad.com
-
General Inquiries
help@myriad.com
-
Unclassified inbox
cscomments@myriad.com
-
Unclassified inbox
sriendeau@myriad.com
-
Unclassified inbox
william.hockett@myriad.com
-
Unclassified inbox
lwalther@myriad.com
OPKO Health
Opko Health engages in the discovery and developmeShow more...nt of novel and proprietary technologies for pharmaceuticals and diagnostics.
Specialized In: Biotechnology, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 5, 2024
Founded Date: 2005
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:OPK
Operating Status: Active
10 Emails
1 Phones
Main email format: ssmith@opko.com (100.0%)
-
Charles Bishop
CEO, Renal Division
c*****p@opko.com
-
Andria Rae Hernandez
Renal Sales Specialist
a********z@opko.com.If
9***********************7
-
Jeff Kurszewski
National Account Director
j*********i@opko.com
-
Gary Nabel
Chief Innovation Officer
g****l@opko.com
-
General Inquiries
contact@opko.com
-
Unclassified inbox
srubin@opko.com
-
Unclassified inbox
kcurtiss@opko.com
-
Unclassified inbox
vmartin@opko.com
-
Unclassified inbox
jgentner@opko.com
-
Unclassified inbox
gfaibish@opko.com
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.